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Abstract 
Increasing antimicrobial resistance in bacteria has led to the need for better understanding 
of antimicrobial usage patterns. In 1999, the World Organisation for Animal Health (OIE) 
recommended that an international ad hoc group should be established to address human 
and animal health risks related to antimicrobial resistance and the contribution of 
antimicrobial usage in veterinary medicine. In European countries the need for continuous 
recording of the usage of veterinary antimicrobials as well as for animal species-specific 
and indication-based data on usage has been acknowledged. 
Finland has been among the first countries to develop prudent use guidelines in 
veterinary medicine, as the Ministry of Agriculture and Forestry issued the first animal 
species-specific indication-based recommendations for antimicrobial use in animals in 
1996. These guidelines have been revised in 2003 and 2009. However, surveillance on the 
species-specific use of antimicrobials in animals has not been performed in Finland. This 
thesis provides animal species-specific information on indication-based antimicrobial 
usage. Different methods for data collection have been utilized. 
Information on antimicrobial usage in animals has been gathered in four studies 
(studies A-D). Material from studies A, B and C have been used in an overlapping manner 
in the original publications I-IV.   
Study A (original publications I & IV) presents a retrospective cross-sectional survey 
on prescriptions for small animals at the Veterinary Teaching Hospital of the University of 
Helsinki. Prescriptions for antimicrobial agents (n = 2281) were collected and usage 
patterns, such as the indication and length of treatment, were reviewed. Most of the 
prescriptions were for dogs (78%), and primarily for the treatment of skin and ear 
infections most of which were treated with cephalexin for a median period of 14 days. 
Prescriptions for cats (18%) were most often for the treatment of urinary tract infections 
with amoxicillin for a median length of 10 days. 
Study B (original publication II) was a retrospective cross-sectional survey where 
prescriptions for animals were collected from 17 University Pharmacies nationwide. 
Antimicrobial prescriptions (n = 1038) for mainly dogs (65%) and cats (19%) were 
investigated. In this study, cephalexin and amoxicillin were also the most frequently used 
drugs for dogs and cats, respectively. 
In study C (original publications III & IV), the indication-based usage of 
antimicrobials of practicing veterinarians was analyzed by using a prospective 
questionnaire. Randomly selected practicing veterinarians in Finland (n = 262) recorded 
all their antimicrobial usage during a 7-day study period. Cattle (46%) with mastitis were 
the most common patients receiving antimicrobial treatment, generally intramuscular 
penicillin G or intramammary treatment with ampicillin and cloxacillin. The median 
length of treatment was four days, regardless of the route of administration. 
Antimicrobial use in horses was evaluated in study D, the results of which are 
previously unpublished. Firstly, data collected with the prospective questionnaire from the 
practicing veterinarians showed that horses (n = 89) were frequently treated for skin or 
wound infections by using penicillin G or trimethoprim-sulfadiazine. The mean duration 
of treatment was five to seven days. Secondly, according to retrospective data collected 
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from patient records, horses (n = 74) that underwent colic surgery at the Veterinary 
Teaching Hospital of the University of Helsinki were generally treated according to 
national and hospital recommendations; penicillin G and gentamicin was administered 
preoperatively and treatment was continued for a median of three days postoperatively.  
In conclusion, Finnish veterinarians followed well the national prudent use guidelines. 
Narrow-spectrum antimicrobials were preferred and, for instance, fluoroquinolones were 
used sparingly. Prescription studies seemed to give good information on antimicrobials 
usage, especially when combined with complementary information from patient records. 
A prospective questionnaire study provided a fair amount of valuable data on several 
animal species. Electronic surveys are worthwhile exploiting in the future. 
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1 Introduction 
Emerging bacterial resistance to antimicrobials can be considered as one of the biggest 
current and future threats to the welfare of mankind. Ever since the discovery of the first 
active substances for killing human pathogenic microbes, resistance has been evolving 
towards these life-saving drugs. Bacteria always seem to be one step ahead of the 
development of new antibacterial drugs. After a century of being effective in curing disease, 
antimicrobials are losing their effect. The importance of bacterial resistance in animals is 
focused on the zoonotic nature of certain animal pathogens and the possibility of transfer of 
elements conferring resistance from animal bacteria to human bacteria. This has been shown 
to happen, for example, in Salmonella spp. isolated from food producing animals and humans 
(Dunne et al. 2000). 
The development of bacterial resistance to antimicrobials is a complex issue. It has, 
however, been shown that the use of antimicrobial agents aggravates the problem, and that 
suboptimal dosing (Harigaya et al. 2009) and prolonged periods of treatment (Guillemot et al. 
1998), in particular, induce and promote resistance. The use of antimicrobials as growth 
promoters in livestock was prohibited by law in the European Union (Commission Directive 
97/6/EC) after it was demonstrated that there was increasing resistance to vancomycin in 
enterococci isolated from poultry (Bager et al. 1997). Vancomycin is a critically important 
drug in human medicine and is used in the treatment of life-threatening infections caused by 
Gram-positive bacteria. The use of avoparcin, a glycopeptide analogue of vancomycin, as a 
production enhancer was thought to cause cross-resistance to vancomycin (Wegener 1999), 
and was therefore banned along with virginiamycin and other antimicrobial agents commonly 
used for growth promoting purposes. The use of cephalosporins and fluoroquinolones has 
been shown to be a risk factor for acquisition of genes coding for the expression of extended 
spectrum betalactamases in Gram-negative bacteria (Kaier et al. 2009). Cephalosporins are 
frequently used antimicrobials in companion animals in several countries (Regula et al. 2009, 
SVARM 2008, Weese 2006). The use of fluoroquinolones has also increased in companion 
animals (DANMAP 2008, Prescott et al. 2002), and consequently also the risk of multidrug-
resistant infections (Black et al. 2009, Cooke et al. 2002).  
In discussions of the impact of antimicrobial use in animals on public health, emphasis is 
put on food-producing animals and the risk for transmission of bacterial resistance via human 
consumption of food of animal origin. However, the growing rate of resistant bacteria 
isolated from infections in companion animals is a major point of concern. Companion 
animals live in close proximity to humans and the risk of transmission of resistant bacteria or 
genetic material conferring resistance cannot be overlooked. Therefore, it is utmost important 
that veterinarians are aware of and recognize the importance of judicious antimicrobial use 
when treating any animal species. 
Prudent use guidelines or detailed indication-based instructions on antimicrobial use in 
animals have been issued in several countries; however, studies on how well guidelines or 
instructions are followed are very few (Regula et al. 2009, Weese 2006). The need for 
guidelines and surveillance is usually argued by attempts to minimize the development of 
antimicrobial resistance in bacteria, and thus avoid the overuse or misuse of potentially 
lifesaving drugs (Nunnery et al. 2006, WHO 2003, WHO 2004). In order to assess the effects 
of guiding antimicrobial use, follow-up studies are needed. 
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This thesis presents baseline information on the indication-based use of antimicrobials in 
four different animal species in Finland. Compliance with guidelines has also been evaluated. 
The literature review includes recently published articles on antimicrobial usage in dogs, cats, 
cattle and horses, introductions of prudent use guidelines and methods that have been used 
worldwide for the collection of antimicrobial usage data in animals. Animal species-specific 
results on usage are previously reviewed and discussed in the original publications I-IV and 
further in this dissertation summary. 
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2 Review of the literature 
The OIE has given recommendations on how to implement systems for monitoring the 
quantity of antimicrobials used in animal husbandry in the OIE member countries (OIE 
2008). The recommendations include examples of sources for antimicrobial usage data 
collection and what type of data should be collected. This information is needed to aid in the 
surveillance of antimicrobial resistance in animal pathogens and also to be able to assess 
whether prudent use guidelines are followed.  
In the following sections, recent literature concerning the clinical use of antimicrobials in 
animals is reviewed and the principles of prudent use guidelines are presented. Furthermore, 
the most frequently used methods for gathering data on antimicrobial use are reviewed. An 
insight into Finnish legislation on the distribution and use of veterinary medicines is also 
given.  
2.1 The clinical use of antimicrobials in dogs, cats, cattle and 
horses 
There have been rather few controlled studies in which antimicrobial use in different 
infectious conditions in animals has been investigated from an indication point-of-view. 
Clinical case reports are available on the treatment of infectious diseases in individual 
animals or animal groups, but the reasoning behind the choice of antimicrobial agent is not 
usually discussed. 
2.1.1 Dogs 
In a Danish study by Pedersen et al. (2007), the use of antimicrobials in dogs and 
antimicrobial resistance in canine pathogens was reviewed. The isolated microbes were from 
clinical diagnostic samples; however, information on which infection had been treated with 
which antimicrobial was lacking. The authors state that skin, ear and wound infections as 
well as gastrointestinal infections and urinary tract infections were the most commonly 
treated infectious conditions in dogs, although no reference is given. The most commonly 
used drugs in dogs in Denmark in 2005, measured in kilograms of active substance, were 
betalactams (75%) and trimethoprim-sulfonamides (13%). Approximately 80% of these were 
oral antimicrobials. This correlates to the usage in Sweden, where betalactams accounted for 
72% and trimethoprim-sulfonamides for 9% of the amount (kg) of peroral antimicrobials sold 
for dogs and cats in 1998. In Norway the respective usage of betalactams was only 10%, and 
of trimethoprim-sulfonamides 82% of the cases (Odensvik et al. 2001). The reason for this 
small proportion of betalactams used in Norway could have been that no peroral betalactam 
antimicrobials were approved for use in animals in the country before 1994. However, a 
study by Grave et al. (1992) revealed that human preparations were widely used in Norway. 
Sixty-three percent of prescriptions for dogs were for a preparation registered for human use. 
Therefore, it can be assumed that human-registered betalactam antimicrobials were used for 
dogs in Norway. 
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A study by Meyers et al. (2008) investigated the bacteriology of bite wounds in dogs in 
South Africa. Based on the susceptibility pattern of bacteria isolated from dog bite wounds, 
the authors suggested that antimicrobial treatment with aminopenicillins combined with 
clavulanic acid to be the best choice for empirical treatment. 
2.1.2 Cats 
There have been few recent articles on antimicrobial usage in cats. One of them concerned 
the treatment of lower respiratory tract infections caused by Bordetella bronchiseptica, which 
is the most common causative agent of the disease in cat rescue shelters and multi-cat 
households (Egberink et al. 2009).  B. bronchiseptica is considered to be a primary pathogen 
of domestic cats with signs of respiratory infection. The bacterium can be isolated by 
broncoalveolar lavage and first-line treatment is with doxycycline (Sherding 2000). 
Tetracyclines, especially doxycycline, are considered as drugs of choice for the treatment 
of Chlamydophila felis infections in cats (Gruffyd-Jones et al. 2009). Other microorganisms 
causing respiratory infections in cats include feline calicivirus and feline herpesvirus. Viral 
infections are not primarily treated with antimicrobials, but broad spectrum antibiotics are 
sometimes recommended for the prevention of secondary bacterial infections (Thiry et al. 
2009, Radford et al. 2009). Broad-spectrum antimicrobials are also recommended as 
conjunctive therapy in enteritis associated with feline panleukopenia (Truyen et al. 2009). 
The term broad-spectrum coverage was not further explained in any of these guidelines. 
A comprehensive review on the use of antimicrobials in cats conducted by Albarellos and 
Landoni (2009) presents several classes of antimicrobial drugs and their usefulness in treating 
infectious diseases in cats. It is directed to practicing veterinarians treating feline patients and 
presents an easy-to-understand summary of pharmacokinetic and bacteriological information 
on common infectious diseases in cats. According to this review, amoxicillin-clavulanate is a 
useful drug combination for common diseases such as bite wounds, pyoderma, cystitis and 
upper respiratory tract infections in cats. However, the authors do not comment on the 
superiority of any drug over another, neither the dose nor the length of the treatment, which 
would all be useful for the practicing veterinarian when making decisions on antimicrobial 
treatment.  
2.1.3 Cattle 
A recent study on antimicrobial treatments in dairy operations in the United States has been 
published by Hill et al. (2009). Information on diseases and antimicrobial treatments was 
collected from 21 states, accounting for approximately 70% of all dairy populations in the 
country. The most common indications for antimicrobial treatment in dairy cows were 
mastitis and lameness. Of 858 herds, 85% reported having cows suffering from mastitis. 
Antimicrobials were used for mastitis treatment in 92% of these herds. Cephalosporins or 
other betalactams were used in 39% and 34% of the mastitis cases, respectively. Lameness 
was recorded in 60% of the herds and treated with antimicrobials in 65% of the cases. 
Lameness was most commonly treated with cephalosporins (30%), followed by other 
betalactams (25%) or tetracyclines (23%). The selection of drugs is restricted by a limited 
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number of approved products for production animals. Another important factor affecting the 
choice of product is the length of the milk withdrawal time, which for cephalosporins is zero 
hours and in other betalactams 48-96 hours. The withdrawal period is a major issue when, as 
in the United States, the farmer makes the choice of which antimicrobial drug to use. 
Another study by Gow and Waldner (2009) examined antimicrobial usage in 203 
Canadian beef cow-calf herds during the calving season (1 January – 30 June). Injectable 
antimicrobials were used in 80% of the herds for treating infections in calves and a 
combination of oral and injectable drugs in 46% of the herds. Diarrhoea, pneumonia and 
omphalitis were the most common indications for treatment in calves. Adult heifers and cows 
mainly received antimicrobial treatment for metritis and interdigital necrobasillosis. The 
percentage of herds that had cows or heifers treated with antimicrobials at least once during 
the calving season was 61%. The most commonly used drugs for calves were oral 
sulfonamides and florfenicol, followed by injectable tetracycline. More than half of the herds 
(52%) used injectable tetracyclines in cows, while 21% of the herds reported the use of 
parenteral penicillin. Enrofloxacin was reported to be used for the treatment of diarrhoea in 
calves in 8 herds; otherwise, no clarification on indication-based usage was given in the 
article. 
2.1.4 Horses 
Weese and Cruz (2009) reported results from a retrospective Canadian study on 
antimicrobials used perioperatively in horses undergoing arthroscopic surgery. Preoperative 
parenteral antimicrobials were routinely used, intravenous penicillin being the most 
frequently used agent (93%). The remaining 7% of the patients received penicillin and 
gentamicin. Two horses did not receive any perioperative antimicrobials. The majority of the 
horses (66%) received intravenous antimicrobials for up to 24 hours postoperatively. 
However, in human medicine it has been shown that in clean surgeries, continuing 
antimicrobial treatment beyond the cessation of the surgical procedures does not bring any 
benefit concerning the risk of wound infections (Bratzler et al. 2005). 
According to a questionnaire survey performed on diplomates of the American College of 
Veterinary Surgeons, most of the veterinarians used perioperative antimicrobials in horses 
undergoing colic surgery. If the surgery was uncomplicated, the average duration of treatment 
was 24 hours postoperatively. If the surgery involved enterotomy or resection, most 
veterinarians stated that antimicrobials were used for approximately 3 days postoperatively. 
(Traub-Dargatz et al. 2002) 
2.2 Prudent use guidelines 
The prudent or judicious use of antimicrobials is characterized by optimizing the therapeutic 
effects while minimizing the risk for the development of antimicrobial resistance and 
preserving the efficacy of available drugs in the future. 
Numerous professional groups have published prudent use guidelines on antimicrobial 
use in animals (OIE 2009, AVMA 2008, Ungemach et al. 2006, CVMA 2002, Anthony et al. 
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2001, Wilke 1999, FVE 1999).  The guidelines are referred to when providing education on 
judicious antimicrobial use to veterinarians, students, farmers and pet owners. It is considered 
to be a common responsibility of veterinarians to comply with the guidelines in order to 
preserve human and animal health. The general reasoning of these guidelines is overall quite 
similar. In the following, a brief overview of the basic principles is given. 
a. Antibiotics shall primarily be used for the treatment of an infectious disease caused 
by bacteria. The use of antimicrobials for disease prevention should be restricted to 
cases where an animal is at notable risk of disease and the use of antimicrobials is 
likely to prevent morbidity. In surgery, the use of prophylactic antimicrobials shall 
not replace aseptic techniques. The use of antimicrobials to promote growth was 
prohibited in the European Union in 1997. 
b. Antimicrobials should always be used by or under the supervision of a licensed 
veterinarian. When a veterinarian dispenses or prescribes medicines to be given by 
the animal owner, the veterinarian is responsible for giving the owner detailed 
instructions on how to use the medicine correctly. 
c. When a veterinarian makes the decision about treatment, he/she needs to base the 
choice of the antimicrobial drug on the confirmed or suspected causative agent and 
the susceptibility to antimicrobial medicines. Antibacterials shall be used only in 
cases of a bacterial infection. Substances with a narrow spectrum should always be 
chosen when possible, and drugs classified as critically important in human 
medicine should be avoided. Further, the correct dosage is to be ordered and 
treatment should continue for as long as needed, but avoiding unnecessarily 
prolonged periods of treatment. The risk of adverse effects and cost of treatment 
should also be minimized. 
d. Both veterinarians and farmers must keep a record of all medications used for 
animals, including the dosage and length of the treatment period. Withdrawal 
periods should also be strictly adhered to. 
e. Veterinarians should encourage the producers to improve livestock management 
and to favour disease preventative measures where applicable. This includes using 
grouping of animals, methods such as all-in-all-out, vaccination and improving 
animal nutrition and health care. It is the responsibility of the veterinarians to be 
updated on new methods for disease prevention and also on issues concerning 
antimicrobial resistance. This information should then be transferred to the clients. 
f. The pharmaceutical industry should pay attention to marketing strategies and, 
especially with antimicrobials, take into account prudent use guidelines and 
promote the judicious use of these precious substances. 
g. The usage and disposal of antimicrobials should be carried out in a manner that is 
safe to animals, people and the environment. 
In addition to general prudent use guidelines, some countries have published animal-
species-specific treatment guidelines that give recommendations on the choice of 
antimicrobials in different bacterial infections. The AVMA has developed judicious use 
principles for aquatic animals, companion animals, horses, beef cattle, dairy cattle, poultry 
and swine (www.avma.org/issues, last accessed 15.11.2010). The Danish Veterinary 
Laboratory of the Danish Veterinary and Food Administration has given recommendations 
for the treatment of infectious diseases in poultry, cattle and swine (Fødevarestyrelsen 2009, 
Fødevarestyrelsen 2007). The CVMA has also issued animal species-specific indication-
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based guidelines for poultry, beef cattle and dairy cattle (CVMA 2008 a, b, c). Furthermore, 
Finland has issued the second revision of detailed treatment guidelines for poultry, cattle, 
swine, horses, dogs and cats, fur animals, fish and bees (Evira 2009). 
2.2.1 Finnish guidelines for judicious antimicrobial use in animals 
The Finnish Ministry for Agriculture and Forestry set up a working group in 1995 to establish 
recommendations for the use of antimicrobials in animals and to suggest measures to improve 
the surveillance of antimicrobial resistance in animal pathogens in Finland. There was 
growing concern of bacterial resistance in human medicine, and the need for guidelines on 
prudent antimicrobial use and evidence-based medicine was recognized. The 
recommendations on the judicious use of antimicrobials in animals were a contribution from 
the veterinary field. The booklet, which was first published in 1996, contains indication-
based suggestions on first-line treatments, secondary choices and additional comments for the 
treatment of common infectious diseases in cattle, swine, horses, fish, poultry, dogs and cats, 
bees and fur animals (MMM 1996). When giving the recommendations, several aspects were 
considered: current evidence-based medical literature, the current national animal disease 
status, antimicrobial resistance in domestic bacterial isolates, available medicinal products, 
the pharmacokinetic and -dynamic properties of the available drugs and the subjective 
experiences of clinical efficacy evaluated by different veterinary specialists. The 
recommendations have subsequently been revised in 2003 and 2009 (MMM 2003, Evira 
2009). 
In the latest revision of the recommendations (Evira 2009), most of the updating 
concerned the guidelines for horses; treatment recommendations for ocular infections were 
added and changes in recommended medications were made for several conditions. In the 
renewed recommendations, local perfusion and local infusion techniques are favoured in 
treatment of septic arthritis, osteomyelitis and endometritis in horses. For dogs and cats, 
topical treatment of pyoderma and otitis externa is emphasized. Systemic antimicrobials are 
recommended as second line choices or in conjunction with local medications. The 
indications for the use of fluoroquinolones or higher generation cephalosporins have been 
critically evaluated and their use is advised to be restricted to cases of non-susceptibility to 
other substances. Some examples of changes in recommendations over the years are 
presented in Table 1. 
2.2.2 Surveillance of antimicrobial resistance in animal pathogens in Finland 
National surveillance of antimicrobial resistance is performed by the Finnish Food Safety 
Authority (Evira) (www.evira.fi/portal/en). A systematic surveillance programme called 
FINRES-Vet was established in 2002. Reports on resistance in zoonotic organisms, animal 
pathogens and indicator bacteria are regularly published. In addition, resistance is 
continuously monitored in projects and from clinical samples submitted daily to the Evira 
laboratory. 
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Table 1. Examples of changes in the Finnish national antimicrobial prudent use recommendations 
from 1996 to 2009: first- and second-line choices. 
 
 
The reports by the FINRES-Vet programme demonstrate that even though the resistance 
of animal pathogens in Finland has been considered to be low, an increasing number of cases 
of both clinical infection and asymptomatic carriage of resistant organisms has been reported. 
Drug resistance in Salmonella in cattle, pigs and poultry has increased from no resistance to 
any of the tested antimicrobial agents in 2005 to resistance towards several groups of 
antimicrobials in 2008 and 2009 (Table 2). Finland has a very low prevalence of Salmonella 
in food producing animals, and the national objective is to keep the incidence below 1%. It is, 
however, of concern that resistance has emerged in isolated species of Salmonella within a 
few years. (FINRES-Vet 2004, FINRES-Vet 2005-2006, FINRES-Vet 2007-2009). 
Resistance has increased markedly also in strains of canine Staphylococcus 
(pseud)intermedius, isolated from clinical specimens sent in to the Finnish Food Safety 
Authority from several parts of the country (Table 3) (FINRES-Vet 2004, FINRES-Vet 2005-
2006, FINRES-Vet 2007-2009). In 2009 there was a sudden increase in oxacillin/methicillin 
resistant strains suggestive of an outbreak. The investigation of a possible common source is 
still pending. If this trend stays permanent, this affects significantly on the prudent use 
recommendations of treatment of canine pyoderma as the efficacy of betalactams, including 
cephalosporins, is jeopardized. 
Horses Recommendation 1996 Recommendation 2009 
Rhodococcus equi– 
pneumonia in foals 
1.Erythromycin 
2. Aminoglycoside + 
penicillin G 
 
1. Erythromycin + rifampicin OR  
clarithromycin + rifampicin 
2. Azithromycin + rifampicin 
Wounds penetrating 
articular 
compartments 
Not applicable 1. Local lavage (joint, tendon sheath) and 
intra-articular antibiotic, eg. 
gentamicin/amikacin 
2. Penicillin G + gentamicin 
 
Infectious 
gastrointestinal 
diseases 
(Salmonella, 
clostridia) 
1. Penicillin G 
2. Nitroimidazoles 
1. Isolation, supportive therapy, no 
antimicrobials 
2. Metronidazole (not for salmonella) 
Intensive care, treatment of salmonellosis 
only in life-threatening cases, based on 
susceptibility 
   
Dogs and cats   
Pyoderma 1. Clindamycin or 
trimethoprim-sulfonamides 
2. 1
st
 gen. cephalosporin or 
amoxicillin-clavulanate 
1. Local treatment with chlorhexidine wash 
solution and fucidic acid. 1
st
 gen. 
cephalosporin 
2. Amoxicillin-clavulanate, clindamycin 
(according to susceptibility testing), 
fluoroquinolones (if heavy scar formation) 
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Table 2. Occurrence of resistance (%) in Salmonella spp. isolated from samples from cattle, pigs and 
poultry; meat and eggs in Finland in 2004-2009 (FINRES-Vet 2004, 2005-2006, 2007-2009). 
 
Antimicrobials 2004 
(n = 31) 
2005 
(n = 32) 
2006 
(n = 28) 
2007 
(n = 38) 
2008 
(n = 21) 
2009 
(n = 22
*
) 
   %    
Ampicillin 3 0 0 5 14 23 
Cefotaxime 0§ 0 0 0 0 0 
Chloramphenicol 3 0 0 3 10 14 
Ciprofloxacin NA 0 11 3 5 14 
Gentamicin 0 0 0 0 0 0 
Nalidixid acid 0 0 0 0 5 14 
Sulfametoxazole 3 0 0 16 14 23 
Tetracycline 3 0 0 18 10 14 
Trimethoprim 0 0 0 3 10 0 
* only cattle and poultry included 
§ figure for ceftiofur 
NA not applicable 
 
 
Table 3. Occurrence of resistance (%) in Staphylococcus (pseud)intermedius isolated from canine 
skin, wounds or otitis externa in Finland in 2004-2009 (FINRES-Vet 2004, 2005-2006, 2007-2009). 
 
Antimicrobials 2004 
(n = 46) 
2005-2006 
(n = 47) 
2007 
(n = 31) 
2008 
(n = 49) 
2009 
(n = 70) 
   %   
Cephalotin 2 9 3 7 26 
Clindamycin 17 17 21 12 35 
Enrofloxacin 4 6 6 8 21 
Erythromycin 17 19 24 14 39 
Gentamicin 2 6 0 2 18 
Oxacillin 2 13 3 7 26 
Tetracycline 46 45 24 31 47 
Penicillin 83 72 82 85 85 
2.3 Data collection methods 
There are several ways of collecting data on the use of antimicrobial drugs in animals. The 
choice on which method is most suitable is made based on what specific information is 
sought. Usage data can be collected on different levels, such as manufacturing data, 
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distribution data, prescription data and end-user data (DeVincent and Viola 2006b) or animal 
species-specific usage data (see for example Chauvin et al. 2008, Chicoine et al. 2008, Grave 
et al. 2008).   
Systematic information on antimicrobial drug consumption in animals can be collected as 
sales data from the pharmaceutical industry, such as in the Netherlands (MARAN 2007) and 
the United Kingdom (AMR Report-UK 2004, VMD 2008/09), from pharmacies, as in 
Sweden (SVARM 2008, 2009), or from pharmacies and feed mills, as in Denmark 
(DANMAP 2008, DANMAP 2007). Wholesaler statistics may also be used, as in Finland 
(NAM 2009) and Norway (NORM NORM-Vet 2009). However, in most European countries, 
no systematic surveillance on antimicrobial usage is available (Kools et al. 2008). 
In the United States, the non-profit organization APUA formed a panel in 1999 to 
investigate issues concerning antimicrobial resistance and the use of antimicrobials in 
animals. One of the main conclusions of the 2-year project FAAIR was that information on 
antimicrobial drug use in animals is poorly documented and difficult to collect. As a sequel to 
this, in the spring of 2002 the Advisory Committee on Animal Antimicrobial Use Data 
Collection in the United States was established in order to address methodological issues 
surrounding animal antimicrobial use surveillance (DeVincent and Viola 2006a). The 
committee consisted of 17 members who represented academics/researchers, government 
officials, animal health industry representatives, public interest scientists and advocates, food 
animal producers and veterinary professionals. The committee was assigned to identify and 
describe different methods for collecting data on antimicrobial usage in animals. Each 
stakeholder was also asked to inform of relevant issues concerning the surveillance of 
antimicrobial use from their point of view. These inputs resulted in stakeholder position 
papers from the perspective of, for instance, an economist, a small animal veterinarian, a 
dairy producer, the animal health pharmaceutical industry and public health. Concerning the 
methodological options, the committee did not reach a uniform conclusion on which method 
or methods would be the best for collecting information on antimicrobial use in the United 
States. However, there was mutual agreement that a combination of two or more methods 
would together give sufficient and accurate information. A summary of the different methods 
and the views of each stakeholder were published in a special issue of Preventive Veterinary 
Medicine (Prev Vet Med (2006) Vol 73, Issues 2-3). 
2.3.1 Wholesaler or pharmacy sales data 
Data collection from wholesalers or pharmacies is useful when reviewing annual national 
trends and for international comparison, as they provide comparable figures on the total 
amount in kilograms of the distributed antimicrobial substances. Several EU countries 
compile and publish annual consumption data, for instance Denmark (DANMAP 2007, 
2008), Norway (NORM NORM-Vet 2007, 2008, 2009), Sweden (SVARM 2008, 2009), 
Finland (NAM 2009), the Netherlands (MARAN 2007) and the United Kingdom (AMR 
Report-UK 2004, VMD 2008/09). The figures of sold antimicrobials are usually shown in 
tonnes of active substance. Companion animals such as dogs and cats are due to their small 
body weight using a neglible amount of antimicrobials counted in kilograms active substance 
than production animals such as cattle, pigs and horses. The statistics database Eurostat 
maintained by the European Commission shows figures on meat production in tonnes of 
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carcasses slaughtered annually (Eurostat 2009) which gives perspective to the used amount of 
antimicrobials in different countries. 
The CVMP has carried out a qualitative risk assessment on antimicrobial resistance and 
collected background information on resistance surveillance and antimicrobial usage in the 
European Union in 1999 (EMEA 1999). Concerning antimicrobial usage data, the CVMP 
concluded that information on amounts and consumption patterns are, with a few exceptions, 
not available. The CVMP recommended regular species-specific monitoring of all 
antimicrobials used in animals.  
The Finnish Medicines Agency Fimea (former National Agency for Medicines, NAM) 
has since 1995 provided annual figures on the sales of different groups of antimicrobial 
substances registered for animals based on the sales data from wholesalers (NAM 2009). 
These figures are comparable between years and they can be compared against the annual 
numbers of registered production animals in order to determine whether overall consumption 
is rising or declining. Information on veterinary drug sales is collected from wholesaler 
statistics also in Norway (NORM NORM-Vet 2007, 2008 and 2009). 
Swedish data are collected from pharmacies, as all pharmacies in the country belong to 
the National Corporation of Swedish Pharmacies, Apoteket AB, and all antimicrobials for 
animals are dispensed via a veterinary prescription. Species-specific sales data are reported 
on an annual basis (SVARM 2008). Previously, Swedish data were collected from the 
wholesalers who sell the drugs to pharmacies. 
Odensvik and colleagues (2001) used data from Sweden and Norway to report 
antimicrobial drug use in dogs and cats over a 9-year period. Although only crude data on 
sold packages were available, it enables the sales trends over the years to be examined. The 
number of sold packages increased steadily in both countries during the study period. In 
Sweden the number of sold packages was doubled during the study period when the number 
of animals stayed the same. 
The most detailed surveillance system for animal antimicrobial usage is in Denmark. The 
Danish VetStat system collects information from pharmacies, which provide 95% of all 
antimicrobials used in production animals in the country (Stege et al. 2003). In addition to 
pharmacies, a small proportion is distributed to end-users by feed mills. Pharmacies report 
monthly information on all dispensed prescriptions. Information on the animal species and 
dosage can be obtained from this prescription data.  
Based on the sources mentioned above, Table 4 shows the annual usage of veterinary 
antimicrobials in proportion to kilograms of meat produced in Norway, Finland, Sweden and 
Denmark in 2008. 
In France, the monitoring of antimicrobials is performed by the AFSSA ANMV. The data 
is collected from marketing authorization holders by sending them a questionnaire and 
requesting the amount of antimicrobials sold between the 1 January and the 31 December 
each year. The information is converted to tonnes of active substance in order to facilitate 
comparison. In a study by Moulin et al. (2008) the usage of antimicrobials in veterinary 
medicine from 1999 to 2005 is reviewed. The consumption of antimicrobials of different 
classes was steady during the study period without any significant increase or decrease in any 
class. Tetracyclines were used the most, approximately 650 tonnes a year, followed by 
trimethoprim-sulfonamides; 250 tonnes a year. 
Wholesaler or pharmacy sales of antimicrobials registered for veterinary use give crude 
information on the scale of antimicrobial usage in different countries. When put into 
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proportion with the information on e.g. head count of production animals or kilograms of 
meat produced annually you get a comparable figure. 
 
Table 4. Sales of antimicrobial drugs for veterinary use in Norway, Sweden, Finland and Denmark in 
2008 expressed in mg of active antibacterial substance sold per kg of slaughtered meat. 
 
Sales of antimicrobials Norway Sweden Finland Denmark 
Antimicrobials (AM tonnes) 7,21 16,42 17,03 120,24 
Meat production (MP tonnes) 318,0005
 
526,200
6 
401,300
6 
2,014,600
6 
AM/MP mg/kg  
(milligrams of active substance/kg meat produced) 
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31 
 
42 
 
60 
1 NORM NORM-Vet 2008 
2 SVARM 2008 
3 NAM 2009  
4 DANMAP 2008 
5 KLF 2009 
6 EUROSTAT 2009 
2.3.2 Prescription data 
A prescription is a veterinarians’ order to the pharmacy to dispense a certain medication to 
whomever the prescription is addressed to. In Finland, the information required in a 
prescription is enacted in a Decree of the Ministry of Agriculture (MMMa 7/EEO/2008). 
Therefore, in addition to collecting data on drug use in animals, prescription habits can also 
be evaluated.  
In some countries, such as Sweden and Norway, all veterinary antimicrobials are 
available by prescription only. Nationwide information is gathered from wholesaler statistics 
or veterinary drugs dispensed from pharmacies to veterinarians or end-users. In order to be 
able to definitely say to what animal species and for which condition a certain drug was 
dispensed, farm-level data has to be added to sales figures from pharmacies. (Grave et al. 
1999) 
In a Swedish-Norwegian study (Grave et al. 1999), information about antimicrobial drug 
use in cattle was examined with special reference to mastitis. Veterinary formulations 
registered for mastitis in cattle were identified and in order to be able to compare different 
formulations and dosages of the same drug, a tentative defined daily dose per cow (DDDcow) 
was implemented. WHO’s definition on a defined daily dose (DDD) is a statistical 
measurement on drug consumption in humans where the DDD is the assumed average 
maintenance dose per day for a drug used for its main indication in adults. A point of 
comparison was developed by calculating DDDcow/1000 cows at risk per day. Cows at risk 
were defined as the counted number of dairy cows on 31 July in each year. Assessments of 
annual variations and trends could then be recorded and results from the two countries could 
be compared. Briefly, the study showed that the use of injectable antimicrobials for the 
treatment of mastitis in cows in Sweden was almost double that in Norway. The use of 
enrofloxacin in cows was 3- to 8-fold greater in Sweden than in Norway. Intramammaries, 
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however, were used three to four times more frequently in Norway than in Sweden during the 
years 1990-1997. The authors considered this to be mainly due to differences in treatment 
practises. Although this DDDcow principle was introduced 10 years ago, for some reason it 
has not gained popularity. One reason could be that there are major differences in dose and 
dosing intervals between countries. 
Chauvin et al. (2002) surveyed French veterinary pig practitioners on their prescribing 
habits. Using a questionnaire, the authors collected information on the last group-level 
antimicrobial treatment prescribed by the corresponding veterinarian. Information on the 
clinical indication or diagnosis was collected together with the product name, dosage and 
length of treatment. Information from a total of 159 prescriptions was reviewed. Diarrhoea 
and cough were the most common indications for the use of antimicrobials in pigs. Colistin 
and tylosin were used in diarrhoea and penicillins and tetracyclines in respiratory diseases. 
Dosages were within commonly approved limits and the treatment period varied from 3 to 21 
days. 
Pedersen et al. (2007) reported in kilograms the quantities of different antimicrobial 
substances sold for companion animals in Denmark in 2005. Information was derived from 
the centralized database VetStat, which is funded by the Danish Ministry of Food, 
Agriculture and Fisheries (Stege et al. 2003). Information was also collected from 
prescriptions on drugs registered for small animals that were dispensed from pharmacies to 
companion animals or veterinary practises. Betalactams and cephalosporins accounted for 
75% of the antimicrobials sold for companion animals in 2005. As the article concentrated on 
antimicrobial resistance, no further information on drug usage was reported. 
Similar to Finland, in Switzerland most of the antimicrobials are sold from distributors 
directly to veterinarians and not via pharmacies. Therefore, end-user data or veterinary 
prescription data are the only reliable sources to study the animal species-specific indication-
based usage of antimicrobials in animals. Regula et al. (2009) performed a large study in 
which they collected information from prescriptions made by veterinarians during a 2-year 
period. Eight practices, mainly working with food-producing animals, were recruited. A total 
of 61 212 treatments with antimicrobials were recorded. In large animals (cattle, pigs and 
horses), sulfonamides and tetracyclines were the most frequently used antimicrobials. In 
small animals, betalactams and cephalosporins accounted for three quarters of all 
antimicrobials used. Detailed indication-based information was not possible to gather because 
veterinarians infrequently reported the indication for use and number of treated animals. 
Weese (2006) carried out a retrospective study on prescriptions for dogs and cats at a 
veterinary teaching hospital in Ontario, Canada. During the 10 years of study, 21 152 
prescriptions were given. An average of 21% of admitted animals received antimicrobials on 
prescription. Betalactams and first-generation cephalosporins were used the most, even in this 
study population. As the study did not investigate for what indication the medications were 
prescribed, compliance with prudent use guidelines on this aspect could not be evaluated. 
As a conclusion, prescription data have a potential to provide very detailed information on 
antimicrobial use in animals, but this necessitates rigorous discipline from veterinarians, i.e. 
they have to complete all fields required in a prescription such as the indication, dosage and 
length of treatment. In addition, prescriptions on different medications dispensed to 
veterinarians as ad usum proprium create some bias, as the target species and indication 
cannot be ascertained.  
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2.3.3 Animal data forms 
Individual animal data forms can be a very valuable tool for collecting information about 
species-specific drug use if the forms have been filled out accurately and completely. In 
Finland, the law requires veterinarians to document all medicines used for animal as well as 
those handed over to animal owners for home care (MMMa 8/EEO/2008). This 
documentation has to include the name of the owner, identification of the animal or group of 
animals, the time and place of delivery and detailed information on the drug, including the 
price.  
2.3.3.1 Electronic patient records 
The use of EPRs provides a systematic tool for documenting patient care, including 
medications. Ideally, national EPR systems would allow patient information to be available 
wherever the patient is treated. This would reduce the cost of repeated laboratory or 
diagnostic imaging measures and facilitates a more accurate review of the patient’s situation, 
as all information is available even if the patient is relocated to another health care facility. 
EPRs should improve the cost-effectiveness of health services, as the need for hand-written 
patient files and their storage is reduced. Computerized systems should also reduce the 
chance of clinical errors and make surveillance of diseases or medications easier. 
As with all electronic systems, there is a growing concern for security issues (The House 
of Commons HC-422-I, 2007). Health data are to be kept private and therefore there is a huge 
demand that EPRs have strict barriers to protect privacy. Only persons truly medically 
involved in the care of a specific patient are to access the files. This is usually enabled by 
personal logins and strong access control. In animal care, the issue of privacy is usually not as 
sensitive as in human patients; however veterinarians have an obligation of confidentiality 
towards the clients and their animals (AVMA 2008). 
In veterinary medicine, few studies have been carried out on the implementation of 
electronic patient record programs. Zaninelli et al. (2007) described the integration of a new 
EPR system to the School of Veterinary Medicine in Milan, Italy. The scope of the study was 
to develop and test the compatibility of the EPR program with programs for viewing digital 
images in the department for diagnostic imaging and cardiology. User opinions were asked 
via questionnaires. The vast majority of the users felt that all clinical data was readily 
available, the quality of information was satisfactory and that the program made work more 
efficient. 
Pollari and Bonnett (1996) assessed the use of electronic medical records at veterinary 
private practises. They found that mainly basic identification data and pre-coded procedures 
were documented on the computer. Therefore, the electronic record was mainly used for 
administrative and billing reasons rather than as a clinical tool.  
Estberg and others (1998) examined the usefulness of search functions in free-text 
electronic patient records at the Veterinary Medical Teaching Hospital in Davis, California. 
The study group consisted of horses undergoing colic surgery. This is a limited population 
and the surgical findings are predictable enough to make a list of the most common 
diagnoses. For each patient, a diagnosis or description of the surgical finding was recorded in 
a free-text area in the electronic patient record. Surgical reports were compared with the text 
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in this field for each patient and a summary of used terms was made. There was marked 
variability in naming, even though there were no discrepancies between the diagnosis on the 
surgery report and the one recorded on the computer. The authors concluded that to facilitate 
surveillance and research, a uniform naming of diagnoses as a drop-down menu would be 
more user-friendly than free-text records. 
2.3.3.2 Manual data forms 
Despite the computerized world, a large portion of animal health care data is still stored as 
handwritten paper documents. In many veterinary clinics and hospitals, some of the patient 
records are also stored as paper documents, such as cover letters from the referring 
veterinarian, electrocardiography-strips and night-time laboratory results. 
Research in which information has to be derived from written paper forms is a time-
consuming and laborious method for collecting data, but where such data are not available in 
electronic form, it is very valuable. Chauvin and his co-workers (2005) studied the use of 
antimicrobials in poultry in France. Farm owners sent a hand-written form to the 
slaughterhouse before sending a flock for slaughter. This form contained basic information 
such as the age and size of the flock and also more detailed data about medications used in 
the animals. Copies of the forms were then sent to a laboratory, where one of the authors 
entered information from the forms into a computer program for further data analysis. 
Usually, the information in the forms was easy to understand and unambiguous. The authors 
considered the data collection to be cheap and easy, as the only cost was for the postage of 
the forms from the slaughterhouse to the laboratory. However, in a recent study, Chauvin and 
others (2008) agreed that the collection of farm-level data is time-consuming and laborious. 
Ortman and Svensson (2004) conducted a study where information about the use of 
antimicrobials in Swedish heifers was collected. The farmers recorded all usage for 
individual animals on separate forms that were checked every second month by a 
veterinarian, who also transferred the data into individual health records. The data on diseases 
and treatments were further collected into electronic data sheets. In total, information was 
collected from records for over 3000 animals, of which 335 received antimicrobials. The 
authors in this study did not discuss the feasibility of the data collection method.   
2.3.4 Questionnaires 
Questionnaire studies can be used for compiling antimicrobial drug usage data on all levels. 
They are especially suitable for surveying distributors (veterinarians) or end-users (farmers or 
companion animal owners) since they are the ones that make the final decision on how and 
when antimicrobials are used in animal patients.  
2.3.4.1 Surveys of veterinarians 
Chauvin and others (2002) sent out questionnaires to French veterinarians surveying their 
prescription habits for pigs. In France, all antimicrobials are prescription drugs. In order to 
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determine which antimicrobials are used in pork-production, a questionnaire was sent to 
veterinarians in which they were asked to report information on their most recent group-level 
prescription for pigs. The researchers used a one-page questionnaire that was mailed to 
veterinarians specifically working with pigs or with intensive livestock production. The study 
group was selected using a veterinary yearbook. The questionnaire contained basic questions 
about the practice and more detailed questions about the most recent prescription they had 
made for a group of animals. Questions included for example the diagnosis, the prescribed 
drug, dosage and the duration of treatment. To non-respondents, a second copy of the 
questionnaire was sent out 3 weeks after the first one. The overall response rate was 54% 
after the first questionnaire and rose to 70% after the reminder. However, of all the 
respondents, only 37% were actively involved in pig production and had prescribed group-
level treatment to pigs within the enquired time frame. Despite these shortcomings, the 
researchers found a mailed questionnaire to be cost-effective and easier to perform than 
personal or telephone interviews. 
Canadian veterinarians performing bovine surgery were surveyed by Chicoine and others 
(2008) about their use of perioperative antimicrobials. A questionnaire was mailed to 
practitioners who were members of the Western Canadian Association of Bovine 
Practitioners. The survey contained questions about antimicrobial usage habits during 
surgeries performed on cattle. The response rate was 41%. As the replies were anonymous, 
no reminders could be sent out to non-respondents, which could be considered a limitation of 
the study. Other identified limitations were that only a quarter of veterinarians in Western 
Canada are members of the Association and therefore the study sample might not have been 
representative of the entire profession, and that the questions required making estimations of 
antimicrobial use instead of, for instance, continuous recording of daily use. 
A problem encountered in mailed questionnaires is a low response rate. An interesting 
example of a successful response rate is a human study in which the response rate of 100% 
was reached (Paradiso-Hardy et al. 2002). The study population comprised of 33 human adult 
cardiac surgery centres in Canada. The one-page questionnaire concerning antimicrobial 
prophylaxis in cardiac surgery accompanied by a cover letter was addressed to the Head of 
Cardiovascular Surgery. Shortly after the first contact, another letter with a copy of the 
questionnaire was sent out to non-respondents. Furthermore, a reminder by phone was given 
to those who had not responded after the second contact. By this method, all centres 
responded to the survey. The high response rate is not discussed in the article, but the low 
number of targets and two contacts by mail followed by a phone reminder probably had a 
significant influence on the response rate. Also, the fact that the questionnaire was short and 
concerned a limited specialist field probably interested the respondents and encouraged them 
to reply. 
2.3.4.2 Surveys of end-users  
As a part of a larger Western Canadian study on cow-calf herds, Gow and Waldner (2009) 
studied antimicrobial use in these herds. As animal records did not give enough detailed 
information on antimicrobial use, a questionnaire directed to herd owners was used at the end 
of the study to complete the missing information. As the quality of animal treatment records 
was in 20% of the cases assessed as less than satisfactory and the questionnaire was given at 
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the end of the study, the overall quality of the usage information was less than optimal. The 
authors suggested that to obtain the best possible information, prospective recording of 
individual animal treatments would be required.  
Similar studies have also been conducted on antimicrobial usage for pigs in Western 
Canada by Rajić and others (2006). Herd owners were asked to complete a questionnaire on 
antimicrobial use indicating whether antimicrobials had been used in feed or water or for 
therapeutic purposes during the previous 12 months. A significant finding was that over 60% 
of the farms used antimicrobials added to the feed during the entire growth phase of a pig.  
Therefore, even if the study was conducted retrospectively, reliance on the farm owner’s 
memory should not present a significant bias since the usage was continuous and persistent. 
The questionnaire itself lacked questions about the type of use, dosage and duration of 
treatment, issues that the authors noted as limitations of their study. 
Stevens and others (2007) carried out an analogous study on pigs in the UK, also using a 
mailed questionnaire to farmers. The response rate was rather low (26%), even though a 
reminder was sent and a prize was raffled amongst the respondents. The authors discussed the 
reasons for the low response rate and presumed that non-respondents might not have wanted 
to reveal their unrigorous usage patterns. The questionnaire was nine pages long and took up 
to 45 minutes to complete. This could have affected the response rate, while a shorter 
questionnaire could have resulted in a higher response rate. 
2.3.4.3 Owner compliance 
Owner compliance is an elementary aspect when interpreting usage data. The fact that a 
veterinarian has prescribed a course of antibiotics to an animal does not automatically tell that 
the drug is given to the animal or how accurately it is given. Several studies on owner 
compliance have been carried out and have indicated considerable variability in how 
accurately antimicrobials are administered to animals. Owner compliance is often 
investigated using questionnaires either completed at the time of the control visit (Adams et 
al. 2005) or by giving the questionnaire to the owner at the same time as the prescription is 
handed over. Owner compliance surveys by telephone can also be performed (Grave and 
Tanem 1999). 
In a study performed by Adams and others (2005), both the veterinarian treating the 
animal and the animal owner filled out separate questionnaires concerning how accurately the 
owner had followed the instructions given by the veterinarian. Client self-report turned out to 
be an inaccurate way of assessing client compliance, because the clients often over-estimated 
themselves as being more compliant than a pill count revealed them to be. Furthermore, the 
authors reported the major problem with questionnaires being unanswered questions or 
complete non-response. 
Grave and Tanem (1999) also used pill counts as a tool for investigating client 
compliance. However, instead of having independent reviewers perform the pill count, as in 
the study of Adams et al. (2005), they enrolled the owners to do the pill count and the 
information was gathered by using a telephone interview. The owners were unaware of the 
study until they were contacted by phone. The authors discussed the problems with having 
the owner do the pill count instead of the investigator and concluded that this might have 
falsely given a higher rate of compliance, as animal owners often overestimate their 
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compliance. Exactly which types of questions were asked, how many questions there were 
and possible limitations of the study caused by the inquiry form were not discussed. 
2.4 Regulations on the distribution, prescription and use of 
antimicrobials in animals in Finland 
In Finland, as in Sweden and Norway (Odensvik et al. 2001), all systemically administered 
antimicrobial drugs for animals are available on prescription only (NAM 2003). In Finland, 
veterinarians are allowed to buy medicinal products directly from wholesalers or from 
pharmacies. Veterinarians are also allowed to dispense drugs for the treatment of animals or 
groups of animals that they have examined and treated or have an ongoing healthcare 
surveillance agreement with. This is different compared, for example, to Denmark, where 
veterinarians do not have the right to dispense, but all veterinary medications are available 
via pharmacies. Furthermore, Danish wholesalers can only distribute medicines to 
pharmacies or other wholesalers (www.dvfa.dk last accessed 15.11.2010). 
According to the Decree of the Ministry of Agriculture and Forestry on the use and 
distribution of veterinary medicinal products in Finland (MMMa 6/EEO/2008), a veterinarian 
has to choose the treatment that is best for the animal both medically and from an animal 
welfare point of view. The choice is made in mutual understanding between the veterinarian 
and the animal owner. The veterinarian has to comply with instructions and restrictions of 
use, which have been set when the marketing authorization has been granted for the 
veterinary medicinal product. If national recommendations for use are given for certain 
treatments, these also need to be taken into account. Concerning antimicrobials in specific, 
the Decree stipulates that if a veterinarian dispenses antimicrobials to treat a group of food-
producing animals of a certain age and for the same indication more than twice a year, 
bacteriological culture and susceptibility testing of the causative agent has to be performed 
before the next treatment. Further, a veterinarian can dispense antimicrobials only for the 
treatment of a current disease. However, if the veterinarian and herd owner have signed a 
healthcare surveillance agreement and the veterinarian visits the farm 4-6 times a year, 
injectable antimicrobials can be dispensed for the later treatment of septic arthritis or tail 
biting in fattening pigs and piglets. 
According to the Finnish Medicines Act (395/1987), a veterinarian who dispenses 
medicines to animal owners is not allowed to gain any financial benefit or to obtain income 
from profitable sale of the medicines.  
The use of drugs in animals is further regulated by the cascade provisions of the Ministry 
of Agriculture and Forestry and the European Parliament and of the Council (MMMa 
6/EEO/2008, Article 10 of Directive 2001/82/EC amended by Directive 2004/28/EC), which 
declare that animals have to primarily be treated with medicines that have been approved for 
use in that animal species and for the specific indication of concern. Secondary options are 
that an animal is treated with a drug approved for that species but for another indication or for 
another species. If no suitable treatment fulfilling these criteria is available, the veterinarian 
can choose a product approved for humans or a preparation available on special license from 
the NAM. As a last resort, an ex tempore preparation can be prescribed. The cascade is 
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restricted to food-producing animals, as only active substances for which a MRL has been 
established can be used (EU 37/2010 (Table 1), EC 470/2009).  
Horses are classified as food-producing animals, although in Finland the annual number 
of horses slaughtered for human consumption is very low, being 770 horses in 2008 and 833 
in January-October 2010  compared to 266 815 cows that were slaughtered in 2008 and 
190 927 in January-October 2010 (www.matilda.fi → Teurastamotilasto. Last accessed 
15.11.2010). In addition to medicines approved for use in food-producing animals, horses 
that have a valid equine passport can be treated with substances approved by the European 
Commission (EC No 1950/2006). This regulation provides a list of substances essential for 
the treatment of equidae. The antimicrobials listed are ticarcillin for Klebsiella spp. 
infections, azithromycin and rifampin for the treatment of Rhodococcus equi infections and 
amikacin for septic arthritis as an alternative to gentamicin or other aminoglycosides. These 
antibiotics can be used in horses with a withdrawal period of 6 months. Horses that have been 
treated with, for example, metronidazole or other antimicrobials listed in Commission 
Regulation EU 37/2010, Table 2 cannot be slaughtered for human consumption, because no 
MRL has been established for these substances. 
A Finnish national Regulation of the Ministry of Agriculture and Forestry on restriction of 
the usage of certain drugs for the treatment of animals first entered into force in 1996 
(MMMp 515/1996). The Regulation was established to ensure that no such drugs are used in 
animals that can harm human health, animals or the environment or jeopardize the treatment 
of diseases in humans. In 1998, section 3a was added prohibiting the use of certain 
antimicrobials in animals (MMMp 935/1998). The Regulation was replaced in 2008 by a 
Decree of the Ministry of Agriculture and Forestry (MMMa 847/2008) and presently the 11th 
section of the Decree comprises a list of antimicrobial agents that are prohibited for use in all 
animal species in Finland: 
1) avoparcin, vancomycin and teicoplanin 
2) virginiamycin 
3) third and fourth generation cephalosporins 
4) rifampicin and rifabutin (rifabutin added in 2008) 
5) moxifloxacin, ofloxacin, levofloxacin and gatifloxacin, with the exception of local 
treatment of ocular infections in horses and companion animals (added in 2008) 
6) tigecycline (added in 2008) 
7) mupirocin (added in 2008) 
8) telitromycin (added in 2008) 
9) daptomycin (added in 2008) 
10) linezolid (added in 2008) 
11) quinupristine-dalfopristine (added in 2008) 
12) carbapenems (added in 2008) 
13) monobactams (added in 2008) 
 
The abovementioned drugs can, however, be used in animals if the drug has marketing 
approval in Finland or it is available as a veterinary product on a special license issued by 
Fimea. In order to obtain such a special license, the veterinarian has to provide sufficient 
scientific evidence that no approved product is useful for the animal or animals. As an 
exception to the Decree, rifampicin can be used in combination with azithromycin, 
erythromycin or clarithromycin for the treatment of infections caused by Rhodococcus equi in 
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foals. To date, two products containing a third-generation cephalosporin have been approved 
in Finland by the centralized authorisation procedure of the European Union, i.e. cefovecin 
registered for dogs and cats and ceftiofur for cattle and pigs, and thus they can be legally used 
for these animal species. 
In addition to the abovementioned list, the use of antimicrobials such as nitrofurans, 
nitroimidazoles (for example metronidazole) and chloramphenicol is forbidden in food-
producing animals due to their potential hazard to human health (section 9 of MMMa 
847/2008). These drugs can, however, be used in horses that have been removed from the 
food chain by making a note in the individual equine passport (EC 1950/2006). 
Overall, the use of antimicrobials in animals in Finland is widely restricted by law. So far, 
the relatively low grade of resistance in animal pathogens has enabled the use of narrow-
spectrum drugs and a rather limited arsenal of antimicrobials. 
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3 Aims of the study 
1. To explore the clinical use of antimicrobials in dogs, cats, cattle and horses in 
Finland; 
2. To analyze the antimicrobial usage with respect to prevailing national animal 
species-specific and indication-based prudent use guidelines on antimicrobial use; 
3. To gain experience of the different methods used for collecting antimicrobial 
usage data in Finland. 
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4 Materials and methods 
Four separate sets of data on antimicrobial use in dogs, cats, cattle and horses (studies A-D) 
were collected and analysed using different methods of data collection. The methods used 
included retrospective cross-sectional surveys of prescriptions, surgery log books and patient 
records from the electronic database of the Veterinary Teaching Hospital of the University of 
Helsinki (later Veterinary Teaching Hospital), a retrospective cross-sectional survey of 
prescriptions from the University Pharmacies and a prospective survey to practitioners on 
antimicrobial usage. Information gathered from studies A, B and C has been published in an 
overlapping manner in the original publications I-IV. 
4.1. Study A: survey of prescriptions from the Veterinary Teaching 
Hospital patient record database (I and IV) 
In study A, data were collected by a retrospective computer search of the patient record 
database of the Veterinary Teaching Hospital. Antimicrobial prescriptions for companion 
animals were included from a 6-month period, November 2000 to April 2001. During the 
study period, 2281 prescriptions were dispensed. Of these, 1780 were for dogs (78%) and 421 
for cats (18%). The additional 91 (4%) prescriptions were for other animals. 
Information such as the patient ID number, animal species, trade name of the drug, 
pharmaceutical form and dosage of the prescribed drug, length of the treatment period and 
the indication was gathered. The data were then sorted by animal species, antimicrobial group 
and indication.  
The Veterinary Teaching Hospital serves as a both a primary care clinic for the larger 
capital city area of Helsinki as well as a referral hospital for patients nationwide. No 
geographical investigation of the patients was performed, but the majority of the patient load 
is from southern parts of the country and areas surrounding the capital city. 
4.2. Study B: survey of prescriptions from the University 
Pharmacies (II) 
A cross-sectional retrospective study on prescriptions for animals dispensed by all University 
Pharmacies (n = 17) in Finland (Table 5) was performed during a one month period in April 
2001. A total of 2719 prescriptions were dispensed, 1898 for dogs (70%), 384 for cats (14%) 
and the rest for other species. Of all prescriptions 53% were for antimicrobials. 
Two persons went manually through the printouts on dispensed prescriptions and 
information was collected into Excel spreadsheets. Pharmacies were asked to provide the 
total numbers of dispensed prescriptions during the investigation period (Table 5). 
The following information was collected from each prescription: animal species, trade 
name of the prescribed drug, formulation, dosage, package size, indication and duration of 
the treatment. It was also recorded whether the prescribed drug was registered for humans or 
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animals. Antimicrobial agents were further divided into subgroups according to the active 
substance. 
The data were grouped according to animal species, antimicrobial group and indication. 
The length of treatment was recorded as a mean and range for all animals of the same species 
receiving a certain drug for a specific condition. 
 
Table 5. Prescriptions dispensed for dogs and cats during April 2001 from University Pharmacies (n 
= 17) in Finland (II, IV). 
 
University 
Pharmacy (n = 17) 
Prescriptions 
for animals 
% of total 
Total number of 
prescriptions 
Helsinki I 3 0.06 4 624 
Helsinki II 547 16.5 3 309 
Helsinki III 226 0.8 27 561 
Helsinki IV 68 0.4 18 270 
Helsinki V 139 0.5 27 405 
Joensuu 304 2 15 578 
Jyväskylä I 163 1 16 258 
Jyväskylä II 7 0.1 5 284 
Kemi 41 0.4 9 682 
Lahti 72 0.4 18 695 
Lappeenranta 154 1.2 13 178 
Oulu 247 1 24 635 
Pori 155 0.9 17 314 
Salo 62 0.5 12 391 
Savonlinna 104 1.1 9 164 
Tampere 245 0.8 30 518 
Turku 182 0.7 24 561 
Total 2 719 1.0 278 427 
4.3. Study C: prospective survey of practitioners (III and IV) 
A prospective cross-sectional survey was carried out via a questionnaire (Appendix 1) sent 
out to randomly selected practitioners nationwide. Ninety-six percent of the Finnish 
veterinarians were members of the Finnish Veterinary Association in 2002. Only practicing 
veterinarians were chosen as the source population (n = 681). Since veterinarians represented 
different type of practices and the size of these groups varied, weighted random computer-
assisted sampling was carried out to ensure a representative sample of each group and to 
ensure that the final respondents would represent the source population (III). 
Practitioners were asked to complete one questionnaire form for each animal they treated 
with antimicrobials during a 7-day period in May 2002. A similar questionnaire survey had 
previously been carried out in human medicine (Rautakorpi et al. 2001), and for veterinary 
purposes this questionnaire was modified in order to take into account veterinary-specific 
aspects (Table 6). Information from all individual animals was separately analysed, even if 
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mass treatment had been carried out. During the study period, 2850 animals received 
antimicrobial treatment, most commonly cattle (n = 1308), dogs (n = 989) and cats (n = 311). 
The duration of clinical signs was estimated by the veterinarian according to the history 
provided by the owner of the animal. The prescribed length of the treatment was counted as 
the treatment duration.  
 
Table 6. Information collected in the prospective survey of practitioners (III, IV) and variables 
entered into the database. 
 
Data recoded Type of 
variable 
Description 
1. Animal species Coded Dog, cat, horse, cattle, pig, fur animal, fish, 
other 
2. Type of visit Coded Normal daytime visit, on-call visit or 
prescription by phone 
3. Main diagnosis Coded 18 pre-coded alternatives or a possibility to 
give own diagnosis 
4. Duration of clinical signs Coded 0-3, 4-7, 8-14 days or longer 
5. Clinical examination or 
diagnostic tests 
Coded 8 pre-coded alternatives1 and possibility to 
describe other tests or procedures 
6. Antimicrobial drug 
administered by the veterinarian 
Text Product name and strength; amount given 
7. Antimicrobial drug given to the 
owner to continue the treatment 
(peroral or injectable) 
Text Product name and strength; duration of 
treatment 
8. Antimicrobial drug given to the 
owner to continue the treatment 
(local treatment, including 
intramammaries) 
Text 
 
Product name and strength; duration of 
treatment 
9. Was the choice of product 
affected by allergy, other 
disease, owner’s wishes, 
recurrent or chronic infection or 
something else? 
Coded  
10. Was this the first visit or a 
follow-up visit? 
 
Coded  
1) Clinical examination, urinary dipstick, secretion microscopy, leucocytes, clavulanic acid test, bacterial 
culture and resistance, X-ray or ultrasound examination, California Mastitis Test 
 
In addition to the questionnaire, each participant received a cover letter explaining the 
aims of the study and instructions on how to fill out the questionnaire. Background 
information was also collected from each respondent. Anonymous responses were accepted, 
although the questionnaire had a number indicating the group to which the responding 
veterinarian belonged. The following background information was collected from each 
participating veterinarian: the geographical area (province), the gender, the year of 
graduation, the degree and the field of specialization. 
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4.3.1. Statistical analysis 
In the prospective survey for practitioners (publications III and IV), a χ2 test was performed 
in order to determine whether the sample population was representative of the source 
population, analysing characteristics such as the type of practice, geographical area, gender, 
year of graduation, degree and field of specialization. These characteristics were pre-coded in 
the questionnaire so it could be transferred into a database in ASCII format. Both SAS 
(version 9.1, SAS Institute Inc, NC, USA) and Microsoft Excel (version 10, Microsoft 
Corporation, Redmond. WA, USA) programs were used for the data analysis. 
4.4 Study D: survey on equine patient records from the Veterinary 
Teaching Hospital (unpublished data) 
The use of antimicrobials for equine patients was studied using two different data collection 
methods. As the equine results have not been previously published, they are presented in this 
thesis in order to share the information. 
The first set of data was collected using a questionnaire survey to practitioners (see 4.3), 
and included information on 89 horses. 
A second study concerning antimicrobial use in horses was performed by utilizing the 
electronic patient records at the Veterinary Teaching Hospital. Antimicrobial usage was 
recorded from a targeted population of horses undergoing colic surgery during 2005-2007. 
The surgery log book and patient-specific anaesthesia forms were examined to collect the 
patients and to record information on administered perioperative antimicrobials. Thereafter, 
the electronic patient records were reviewed and all antimicrobial agents administered to each 
patient were collected in a spreadsheet, along with information on the duration of treatment. 
Only horses that survived until discharge (n = 74) were included in further studies on 
antimicrobial use.  
According to a survey to diplomates of the American College of Veterinary Surgeons in 
the United States of America, antimicrobials should be administered perioperatively and for 
1-10 days postoperatively (Traub-Dargatz et al 2002). The aim of this study was to determine 
the usage patterns at our facility and to unify the practice of antimicrobial use in equine 
patients undergoing colic surgery.  
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5 Results 
The conclusions concerning usage of antimicrobials in dogs and cats, respectively, were 
uniform in studies A and B (dogs) and studies A, B and C (cats), respectively, as can be seen 
from the original publications. To widen the horizon on animal species-specific use, the 
results here are shown per species. 
5.1. Antimicrobial usage in dogs (I and II) 
Antimicrobial usage in dogs was investigated by using two different sets of data: 
prescriptions on antimicrobials for patients at the Veterinary Teaching Hospital (study A) and 
prescriptions dispensed from University Pharmacies (study B). The animal species 
distribution in study A is illustrated in Figure 1 and for study B in Figure 2. From these sets 
of data, further analyses were performed for dogs as well as cats. 
65 %
19 %
16 %
Dog (n = 678)
Cat (n = 196)
Others (n = 164)
 
Figure 1. Distribution of animal species for which peroral antimicrobial drugs were prescribed at the 
Veterinary Teaching Hospital (I, IV) (Ntot = 1732). Others include rodents, rabbits, birds, pigs and 
reptiles.  
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77 %
20 %
3 %
Dog (n = 1324)
Cat (n = 349)
Others (n = 59)
 
Figure 2. Distribution of animal species for which peroral antimicrobial drugs were dispensed from 
the University Pharmacies (II, IV) (Ntot = 1038). Others include cattle, rodents, birds, pigs and fish. 
 
A total of 2739 prescriptions on antimicrobials for dogs were reviewed. Of these, 73% (n 
= 2002) were orally administered antimicrobials. Betalactams were the most frequently 
prescribed peroral antimicrobials, in 66% of the cases in both studies. Table 7 summarises the 
distribution of different groups of antimicrobials prescribed for dogs. 
 
Table 7. Characteristics of the antimicrobial drugs prescribed for dogs at the Veterinary Teaching 
Hospital (I) and dispensed from the University Pharmacies (II). 
 
 Study A 
(Veterinary 
Teaching 
Hospital) 
Study B 
(University 
Pharmacies) 
Prescriptions (ntot = 2739) 1780 959 
   Oral formulations (ntot = 2002) 74% (n = 1324) 71% (n = 678) 
   Topical formulations (ntot = 737) 26% (n = 456) 29% (n = 281) 
   
Distribution of oral drugs   
Betalactams 66% (n = 880) 66% (n = 448) 
   Penicillins and aminopenicillins 19% 16% 
   Amoxicillin-clavulanate 32% 38% 
   Cephalexin 49% 45% 
   
Trimethoprim-sulfonamides 18% 18% 
Lincosamides and macrolides 8% 8% 
Fluoroquinolones * * 
Others 
1 
* 5% 
1
 Aminoglycosides, fungal drugs, metronidazole, nitrofurantoin and tetracyclines  
*
 Minor number of treated animals, total percentage of less than 5% 
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In study A, information was gathered from patient files, in which the diagnosis and reason 
for treatment could be found in 95% (n = 1694) of the cases. In the remaining 5% (n = 86), 
no reason for prescribing an antimicrobial agent could be identified. In study B, the indication 
for which the medication had been prescribed was clearly stated in only 28% (n = 273) of the 
prescriptions. The distribution of different antimicrobials for a variety of conditions in dogs is 
presented in Table 8. 
 
Table 8. Distribution of oral formulations of antimicrobials prescribed for dogs for different 
indications in prescriptions from the Veterinary Teaching Hospital (I) and the University Pharmacies 
(II). 
 
Distribution of oral 
antimicrobials prescribed for 
dogs 
Skin and 
ear infections 
(n = 568) 
Genito-
urinary 
infections 
(n = 248) 
Gastro-
intestinal 
infections 
(n = 225) 
Respiratory 
infections 
(n = 112) 
Betalactams 82% (n =464) 39% (n = 97) 48% (n = 107) 81% (n = 91) 
   Penicillins and aminopenicillins 21% 21% 21% 23% 
   Amoxicillin-clavulanate 19% 64% 67% 47% 
   Cephalexin 60% 15% 12% 30% 
     
Trimethoprim-sulfonamides 6% 50% 18% 10% 
Lincosamides and macrolides 6% * 26% * 
Fluoroquinolones * 9% * * 
Metronidazole * * 6% * 
Others 
1 
* * * * 
1 Fungal drugs, nitrofurantoin and tetracyclines 
* Minor number of treated animals, total percentage of less than 5% 
 
Infections of the skin and external ear canal were the most common reasons for 
prescribing antimicrobial treatment for dogs in both studies, accounting for 45% and 54% of 
the prescriptions, respectively. Both peroral and topical drugs were used for the treatment of 
these diseases. Urinary tract infections were also frequently diagnosed and treated (12% and 
16% of the prescriptions in studies A and B, respectively). 
In systemic treatment of skin and ear infections, betalactams were used the most. 
Cephalexin was the most popular, comprising 49% of all prescriptions. Furthermore, 
amoxicillin+clavulanate was prescribed in 15% of the cases. According to the prevailing 
national antimicrobial guidelines (MMM 1996), they were both second line drugs, as 
clindamycin and trimethoprim-sulfonamides were the recommended first line antimicrobials 
at the time. In study A, the mean period of treatment for skin infections was 14 days with 
cephalexin (range three to 33 days), and 13 days with amoxicillin+clavulanate (range three to 
20 days). 
Trimethoprim-sulfonamides were used most frequently for the treatment of urinary tract 
infections, as 50% of the dogs received trimethoprim-sulfonamides (Table 8). The mean 
treatment period was 9 days (range seven-21 days). In addition, amoxicillin+clavulanate was 
used in 25% of the cases. This usage pattern was consistent with the recommendations. 
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Of the peroral drugs, fluoroquinolones comprised 4% of the prescriptions (Table 7). In 
study B, the majority (40%) of the fluoroquinolones were used for the treatment of 
genitourinary infections. 
5.2. Antimicrobial usage in cats (II and IV) 
The indication-based use of antimicrobials to feline patients was investigated using three 
methods. In study A, prescriptions of antimicrobials for cats treated at the Veterinary 
Teaching Hospital were reviewed. In study B, prescriptions for cats were collected from the 
University Pharmacies in Finland. Finally, in study C, the condition-based use of 
antimicrobials for cats was investigated in a nationwide survey of practitioners. 
A total of 958 cats were treated using antimicrobials in the three studies. Oral drugs were 
the most frequently used, as 77% (n = 738) of the cats received per oral antimicrobials (Table 
9). 
 
Table 9. Characteristics of the antimicrobial drugs prescribed for cats at the Veterinary Teaching 
Hospital (IV), dispensed from the University Pharmacies (II) and used by practitioners participating 
in the nationwide survey (IV)  
 
 Study A 
Veterinary 
Teaching 
Hospital 
Study B 
University 
Pharmacies 
Study C 
Practitioners 
Prescriptions or treatments  
(ntot = 958) 
421 226 311 
   Oral formulations (ntot = 738) 83% (n = 349) 87% (n = 196) 62% (n = 193) 
   Topical formulations (ntot = 220) 17% (n = 72) 13% (n = 30) 38 % (n = 118) 
    
Distribution of oral drugs    
Betalactams 89% (n = 311) 78% (n = 153) 91% (n = 175) 
   Penicillins and aminopenicillins 62% 52% 50% 
   Amoxicillin-clavulanate 26% 39% 42% 
   Cephalexin 12% 10% 7% 
    
Lincosamides and macrolides * 9% * 
Fluoroquinolones * 5% * 
Tetracyclines 5% * * 
Others 
1 
* 6% * 
1 Fungal drugs, metronidazole and trimethoprim-sulfonamides 
* Minor number of treated animals, total percentage of less than 5% 
 
In study A the diagnosis and reason for antimicrobial treatment were available in 94% (n 
= 397) of the cases. In the remaining 6% (n = 24), no valid reason for prescribing an 
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antimicrobial agent could be identified. In study B, the indication for which the medication 
had been prescribed was clearly stated in 38% (n = 85) of the prescriptions. 
The distribution of oral antimicrobials for the four most common conditions is presented 
in Table 10. Skin and ear infections (including bite wounds and scratches) were the most 
common diagnoses in studies A and C. The recommendations were complied with, since the 
most frequently used antimicrobials were betalactams, primarily penicillins and 
aminopenicillins, followed by amoxicillin-clavulanate. Urinary tract infections were the most 
common (study B) or second most common (studies A and C) indication for antimicrobial 
treatment. Aminopenicillins and amoxicillin-clavulanate were the first and second line drugs 
of choice in the guidelines. Compliance with the recommendations was good, as 84% of the 
treatments consisted of these two medications (Table 10).  
 
Table 10. Distribution of oral formulations of antimicrobials used for different indications in cats in 
prescriptions from the Veterinary Teaching Hospital (IV), University Pharmacies (II) and in the 
prospective survey of practitioners (IV). 
 
Distribution of oral 
antimicrobials distributed 
for cats 
Skin and ear 
infections 
(n = 191) 
Genito-
urinary 
infections 
(n = 190) 
Gastro-
intestinal 
infections 
(n = 74) 
Respiratory 
infections 
(n = 69) 
Betalactams 94% (n = 179) 88%(n = 167) 82% (n = 61) 71% (n = 49) 
   Penicillins and aminopenicillins 54% 59% 49% 57% 
   Amoxicillin-clavulanate 30% 36% 48% 35% 
   Cephalexin 16% 5% 3% 8% 
     
Trimethoprim-sulfonamides * 5% * * 
Lincosamides and macrolides * * 16% 6% 
Fluoroquinolones * 7% * * 
Tetracyclines * * * 20% 
Metronidazole or fungal drug  * * * * 
* Minor number of treated animals, total percentage of less than 5% 
5.3. Antimicrobial usage in cattle (III) 
Of the 2850 animals that were treated with antimicrobials during the seven-day questionnaire 
survey of practitioners, cattle were the animal species treated most frequently as 46% (n = 
1308) of the animals were cows. 
Of a total of 262 practitioners who responded to the survey (response rate 38%), 42% (n = 
109) treated cows during the study week. The number of treated animals varied between 1 
and 42, the median and mode being 4 animals. Mastitis and dry-cow therapy were the most 
common indications for antimicrobial therapy in cattle (Figure 3). 
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Figure 3. The four most common reasons for antimicrobial treatment in cattle during the seven-day 
study on practitioners’ antimicrobial usage patterns (III). 
 
In acute mastitis, treatment was initiated within 0-3 days in 70% of the (n = 482). In 18% 
(n = 122) and 4% (n = 30) of the cases, treatment was begun in 4-7 and over 8 days, 
respectively, from the point at which the first signs of mastitis were noticed. 
Acute mastitis was most commonly treated with penicillin G (83%) or enrofloxacin 
(11%). This was in line with the prevailing national recommendations (MMM 1996) which 
suggested that acute mastitis caused by Gram-positive cocci should be treated with penicillin 
G, and if the clinical signs refer to mastitis caused by Escherichia coli, the second line choice 
was enrofloxacin or trimethoprim-sulfonamides. Before initiating systemic antimicrobials, 
supportive therapy should be given and the effect monitored. The median length of treatment 
of acute mastitis was 4 days (range 1-8 days).  
Group treatments (3-20 animals at the same visit) were carried out in 31% (n = 34) cases, 
and during these visits a total of 177 (14%) animals were treated. Of these, 108 (61%) 
animals received dry-cow therapy: 58 cows were administered intramammaries only, 24 cows 
were treated with parenteral drugs, 23 animals were treated with a combination therapy of a 
parenteral drug and intramammaries and three received an oral drug. Of the parenteral drugs, 
benzyl- and procaine penicillin was used most frequently (n = 38; 81%), followed by 
enrofloxacin (n = 5) and oxytetracycline (n = 4). The oral drug used was dihydrostreptomycin 
tablets. 
52 % 
21 % 
6 % 
4 % 
17 % 
Acute mastitis (n = 686) 
Dry cow-therapy (n = 271) 
Chronic or subclinical 
mastitis (n = 78) 
Acute enteritis (n = 49) 
Others (n = 224) 
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5.4. Antimicrobial usage in horses (unpublished data) 
5.4.1. Questionnaire survey 
Antimicrobial use in horses was investigated in a survey of practitioners (study C). During 
the seven-day study period, a total of 89 horses received antimicrobial treatment. Thirteen of 
the horses received only a single dose of an antimicrobial during the primary visit. The rest of 
the horses (n = 76) received antimicrobials as a course. Sixty-eight horses (89%) received 
either benzylpenicillin (n = 36; 47%) or trimethoprim-sulphadiazine (n = 32; 42%). Seven 
horses (9%) were treated with topical preparations only. One horse (1%) received a five-day 
course of gentamicin. 
The diagnosis was mentioned for 60 horses (67%), of which 29 (48%) horses were treated 
with trimethoprim-sulphadiazine and 31 (52%) horses with benzylpenicillin. The most 
common indication was skin infections (n = 21) and infection of the urogenitals, mainly 
retention secundarium and endometritis (n = 18). According to the prevailing Finnish 
guidelines on antimicrobial use, penicillin G and trimethoprim-sulfonamides were the first 
and second line choices in skin infections in horses (MMM 1996). Compliance with the 
guidelines was therefore considered satisfactory. For puerperal endometritis, the 
recommendation was penicillin G combined with either gentamicin or trimethoprim-
sulfonamides. 
The length of the course of treatment was similar, regardless of the indication, 
trimethoprim-sulfadiazine was used for a mean of seven days whereas the mean length of 
treatment with benzylpenicillin was five days (Table 11). 
 
Table 11. The length of antimicrobial treatment of 60 horses which were treated for various infectious 
conditions by veterinarians participating in the prospective survey of practitioners (unpublished 
data). 
 
Antimicrobial drug 
 
Length of treatment (days) 
Mean Mode Min Max 
Trimethoprim-sulfonamides (n = 29) 6,9 7 2 14 
Benzyl penicillin (n = 31) 5,4 5 2 10 
5.4.2. Equine Teaching Hospital patient record data 
A total of 125 horses had colic surgery throughout 2005-2007 at the Veterinary Teaching 
Hospital (study D). Of these, 27 (22%) horses were euthanized or died in surgery and were 
excluded from further studies.  
Of the remaining 98 horses that recovered from surgery, a total of 74 (59%) horses 
survived to discharge from the hospital. The survival-to-discharge rate in horses that needed 
bowel resection was five horses out of 13 (38%), while the rate in the non-resection group 
was 69 horses out of 85 (81%).  
The most frequently used therapy both pre- and postoperatively was the combination of 
penicillin G and gentamicin. This choice was correct according to the prevailing Finnish 
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guidelines on antimicrobial use (MMM 2003). Preoperatively, out of a total of 74 horses, 65 
horses (88%) received antimicrobials, 55 (85%) of them penicillin G and gentamicin. 
Penicillin alone was given to nine horses (12%) and another nine horses were not recorded to 
have received any preoperative antimicrobials. One horse was administered penicillin G and 
trimethoprim-sulfadiazine. 
In the immediate postoperative period <24 hours after surgery, out of a total of 74 horses, 
57 patients were administered antimicrobials; 38 (67%) were given penicillin G and 19 (33%) 
penicillin G combined with gentamicin. Amongst these 57 horses, nine horses did not receive 
any antimicrobials preoperatively. Fourteen horses (78%) that received gentamicin 
postoperatively had not received it preoperatively. 
Antimicrobial treatment was discontinued within the first 24 hours in two horses. The 
remaining 72 horses were medicated for a median of three days (average length of treatment 
10 days; range 0-34 days). The most commonly used medication consisted of penicillin G 
and gentamicin, as 92% (n = 68) were treated with that combination. Horses which were 
treated with penicillin alone or in combination with gentamicin were all treated for a 
maximum of nine days (n = 45; 61%). The longer the course of treatment was the more 
number of drugs were involved. Nineteen horses (26%) received trimethoprim-sulfadiazine, 
11 horses (15%) enrofloxacin, six horses (8%) metronidazole and one horse (1%) 
erythromycin usually in combination with other antimicrobials. 
The length of stay in hospital varied between four to 31 days; 53% of the patients (n = 39) 
stayed in the hospital for 10-14 days. The average length of antimicrobial treatment was 10 
days. No obvious relation between the length of antimicrobial treatment and length of stay in 
hospital was observed. 
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6 Discussion 
Due to growing concern over the further development of antimicrobial resistance in both 
human and veterinary medicine, it is important that detailed information is obtained about 
antimicrobial usage patterns. To achieve this purpose, indication-based and animal species-
specific usage data are needed. On the basis of these data it is possible to assess for which 
indications antimicrobials are being prescribed and whether prudent use guidelines are being 
followed. Information about the usage patterns may also provide a basis for the updating of 
prudent use guidelines and continuing education of veterinarians on the proper use of 
antimicrobials, as well as providing information to animal owners about the risks of 
antimicrobial resistance.  
6.1 Indication-based use of veterinary antimicrobials in Finland and 
compliance with prudent use guidelines and legislation 
 
In our research, emphasis was put on obtaining a detailed overview of the animal species-
specific use of veterinary antimicrobials in Finland, as this information was not previously 
available. Data were collected from prescriptions issued by veterinarians at the Veterinary 
Teaching Hospital, from prescriptions dispensed from the University Pharmacies to end-users 
and by using a questionnaire directed to practicing veterinarians enquiring about their 
antimicrobial usage habits. In addition, direct use in hospitalized patients was investigated. 
Prudent use guidelines were complied with well in all studies, and the use of second line 
drugs, such as fluoroquinolones, was moderate. No illegal use of prohibited antimicrobial 
substances was noted in any of the studies (A-C). Mupirocin had been used in a few dogs and 
cats for topical treatment of skin infections, however, mupirocin was prohibited for use in 
animals only in 2008 (MMMa 847/2008). 
6.1.1 Antimicrobial use in dogs and cats (I, II, IV) 
Antimicrobial agents were the most commonly used group of medicines in small animals in 
Australia (Watson and Maddison 2001) and Norway (Grave et al. 1992). In our research 
aminopenicillins and cephalexin were the most commonly used antimicrobials in dogs and 
cats. Betalactams are also widely used in other Nordic countries (Odensvik et al. 2001). In 
Norway, trimethoprim-sulfonamides were the most commonly used drug in dogs and cats in 
1990-1998. However, betalactams were introduced to the veterinary market as late as 1994. 
Since then, the percentage use of betalactams has increased. (Odensvik et al. 2001). In our 
research material, infections of the skin and wounds were the most common reason for 
antimicrobial treatment in both dogs and cats. According to the national guidelines at the time 
of the collection of our research data, macrolides and lincosamides or trimethoprim-
sulfonamides were the first choices for systemic treatment of skin infections (MMM 1996). 
However, according to our research, amoxicillin-clavulanic acid and cephalexin were the 
drugs used most frequently. Bacteria causing skin infections are commonly staphylococci, 
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which in Finland showed increased resistance to clindamycin at the end of the 20
th
 century 
and was over 20% in 2002-2003 (FINRES-Vet 2001-2005). However, since then the 
resistance to clindamycin has decreased annually and was down to 12% in 2008 (FINRES-
Vet 2007-2009, FINRES-Vet 2005-2006, FINRES-Vet 2001-2005). The resistance of canine 
staphylococci to first generation cephalosporins has been less than 10% until 2009, when it 
suddenly rose to 22% (FINRES-Vet 2007-2009, FINRES-Vet 2005-2006, FINRES-Vet 
2001-2005). This drastic rise is due to an increase in the number of oxacillin resistant strains 
in clinical samples. The investigation of the affair is still pending.  
The national guidelines have been updated subsequently and the most recent 
recommendation for treatment of deep skin infections in dogs and cats is first generation 
cephalosporins and amoxicillin-clavulanate. Clindamycin is recommended for use only after 
susceptibility testing (Evira 2009). This point of the recommendations needs to be closely 
monitored, though, as the percentage of oxacillin/methicillin-resistant strains in canine 
staphylococci is imminently rising and thus makes the bacteria resistant also to 
cephalosporins and other betalactams most commonly used for treatment of skin infections in 
dogs (FINRES-Vet 2007-2009). 
The length of treatment of skin infections in dogs in our studies was approximately 14 
days, which can be considered a rather short course. According to guidelines on effective 
treatment of pyoderma in dogs the recommended length of treatment should extend seven 
days after the clinical signs have withdrawn and typically a course of 3-6 weeks is needed for 
clinical cure (Dowling 1996). There are, however, to my knowledge no controlled studies on 
optimal length of treatment with antimicrobials in infections in animals. It is known that 
suboptimal dosing with low doses and long courses promote the development of 
antimicrobial resistance (Guillemot et al. 1998). Therefore, it would be important to pay 
attention to dosage and length of treatment when giving recommendations on indication-
based antimicrobial use in animals. 
Urinary tract infections in dogs were most commonly treated with trimethoprim-
sulfonamides, which is in line with the national recommendations. In cats, amoxicillin and 
amoxicillin-clavulanic acid were frequently used for urinary tract infections. These are 
mostly effective drugs in treating urinary tract infections caused by bacteria in cats, as the 
most commonly isolated pathogens include susceptible E.coli, Staphylococcus spp. and 
Streptococcus spp. (Kruth 2006). 
6.1.2 Antimicrobial use in cattle 
In our study penicillin G was the most commonly used antimicrobial in cattle. Penicillin was 
also the most frequently used antimicrobial in cattle in Sweden and Norway (Grave et al. 
1999).  
Mastitis is the most common reason for antimicrobial treatment in dairy cattle (Pol and 
Ruegg 2007, Grave et al. 1999). In our study material, acute or subclinical mastitis was the 
indication for treatment in 58% of the cattle. Penicillin G is widely used in mastitis in cattle 
in Finland, as staphylococci frequently cause clinical mastitis in dairy cows (Taponen and 
Pyörälä 2009). The use of penicillin G in mastitis is appropriate, as in Finland 75% of the 
bovine staphylococci are susceptible to penicillin (FINRES-Vet 2005-2006). According to 
the guidelines, penicillin G is the drug of choice when treating mastitis caused by 
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streptococci or penicillin-sensitive staphylococci (Evira 2009). In acute mastitis the treatment 
is usually initiated before the microbiological culture and susceptibility results are ready. 
Therefore, the clinical signs, history of mastitis in the cow in question and history of mastitis 
on a herd level direct the choice of antimicrobial in cases of acute mastitis. Usually 
preliminary results show already after one day whether the causative agent is a gram-positive 
cocci or E.coli and treatment can be corrected thereafter. 
Acute mastitis was in 11% of the cases treated with enrofloxacin, a fluoroquinolone 
recommended as a second-line choice in coliform mastitis. In Finland approximately 12% of 
the acute clinical mastitis cases are caused by coliforms, thus it can be concluded that Finnish 
veterinarians followed the guidelines well (Nevala et al. 2004).  
6.1.3 Antimicrobial use in horses (unpublished data) 
In the study on the antimicrobial usage patterns among practitioners (study C), most horses 
were treated with penicillin G or trimethoprim-sulfonamide, regardless of the condition. This 
is probably due to the minimal arsenal of available approved antimicrobial drugs for horses. 
Antimicrobials registered for use in horses in Finland include trimethoprim-sulfonamide and 
penicillin G (Pharmaca Fennica® Veterinaria 2009). In addition, antimicrobials registered for 
use in other production animals can be used and, if a note has been made in the horse’s 
passport that the horse cannot be slaughtered for human consumption, drugs listed in 
Commission Regulation EU 37/2010 Table 2 can also be used. The majority of the patients in 
the study were treated for skin infections or endometritis. According to the national 
guidelines that were in force when the study was performed, penicillin G and trimethoprim-
sulfonamide were the first- and second-line choices for systemic treatment of superficial skin 
disorders. For endometritis, the recommendation included combining penicillin G with either 
trimethoprim-sulfonamides or gentamicin (MMM 1996). Therefore, it can be concluded that 
the guidelines were fairly well complied with, even though the number of animals was very 
limited. The study was performed during a 7-day period in May, which might have affected 
the proportion of different conditions, as endometritis would probably not be a common 
indication during the winter. The treatment recommendations have been updated in 2009 
(Evira 2009), and concerning skin infections, systemic treatment is listed as a second-line 
choice. Skin infections should primarily be treated locally with antiseptic preparations to 
avoid systemic exposure to antimicrobials. For the same reason, endometritis is now 
recommended to be primarily treated with local uterine lavage, and systemic antimicrobials 
are only used in the case of generalized disease. 
In study D, antimicrobial use in horses undergoing colic surgery was investigated. 
Preoperative administration of antimicrobials was common, as 88% of the horses received 
either penicillin G alone (14%) or combined with gentamicin (85%). Broad spectrum 
antimicrobials are recommended in surgeries where the risk of infection exceeds 5% 
(Southwood 2006). In surgeries where the post-operative risk of infection is high, such as in 
colic surgeries, a perioperative antimicrobial treatment consisting of penicillin G and 
gentamicin is recommended (Santschi 2006). This is in line with results from our study and 
with the national recommendations (MMM 2003). According to an American study by 
Traub-Dargatz et al. (2002) veterinarians who are diplomates of the American College of 
Veterinary Surgeons performing equine surgery at veterinary teaching hospitals also use a 
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preoperative antimicrobial protocol of penicillin G and gentamicin in horses undergoing colic 
surgery. The duration of treatment depends on the clinical findings (Traub-Dargatz et al. 
2002). In horses not requiring bowel resection, the recommended duration of treatment is 72 
hours (three days) postoperatively (Traub-Dargatz et al. 2002, Santschi 2006). The median 
period of treatment in our study was three days. 
In conclusion, Finnish equine practitioners seemed to comply fairly well with national 
prudent use guidelines on antimicrobial usage. 
6.2 Problems and benefits of different data collection methods 
Different methods for data collection on antimicrobial usage in food-producing animals have 
been thoroughly reviewed by The Advisory Committee on Animal Antimicrobial Use Data 
Collection in the United States (DeVincent and Viola 2006a, b). However, considering the 
population and the geographical dimensions of the United States and other large countries 
compared to small countries such as Finland and Scandinavian countries, the methods, aims 
and means for studying antimicrobial usage are different (Table 12). In Finland the 
production structure is similar nationwide and also similar to other Scandinavian countries. In 
Finland for example the dairy units are small, usually family owned and with no paid 
manpower. Herd size on dairy farms varies from tens to one- to two-hundred heads. In 
contrast, 30% of dairy cattle in the United States is farmed in herds of over 2,000 animals 
(USDA 2010). 
 
Table 12. Dimensional differences between Finland, Scandinavia and the United States of America 
(USA). 
 
Countries Population1   Land area (km2)2 Cattle head count3 
Finland 5 400 000 338 145 918 280 
Scandinavia
4 25 500 000 878 213 3 956 179 
USA 309 600 000 9 629 091 94 500 000 
1
 PRB 2010  
2 PRB 2009 
3 TIKE 2009 (Finland), SVJ 2008 (Sweden), Statistics Norway 2009 (Norway), Statistics Denmark 2009 
(Denmark) and NASS 2009 (USA) 
4 Includes Sweden, Norway and Denmark 
6.2.1 Wholesaler and pharmacy sales data 
The OIE recommends all member countries to keep annual records of antimicrobials used in 
animal husbandry (OIE 2008). The easiest way to do this is by using the Veterinary Anatomic 
Therapeutic Chemical classification and requesting wholesalers or pharmacies to provide 
annual sales figures of drugs belonging to each class. Thereby, information on how many 
kilograms of antimicrobials have been sold can be tabulated and compared to previous years. 
Valuable facts on, for example, the use of fluoroquinolones or other substances listed as 
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critically important antimicrobials for human medicine (WHO 2007) can be derived. 
However, because many substances are registered for use in several animal species, 
conclusions on which animals have been treated cannot be drawn. This has been a point of 
discussion for several years among both international expert groups 
(EMEA/CVMP/353297/2005) and in Finland, where the Fimea provides wholesaler statistics 
on annual antimicrobial consumption (NAM 2009). There has been a 25% rise in the use of 
injectable penicillin during the last five years, but no definitive explanation for the rise can be 
given, since it is unclear whether the consumption is increasing in cattle or swine. The use of 
injectable tetracyclines has also increased by a tremendous 300%. The total amount of 
distributed antimicrobials increased from 13 000 kg to almost 17 000 kg during 2001-2008 
(NAM 2009). This rise cannot be explained by an increase in the number of animals, since 
the number of cattle has steadily decreased by 10-20 000 heads per year and the number of 
swine has remained steady since 2000 (www.mmmtike.fi, last accessed 15.11.2010). An 
educated guess is, however, that an increased amount of antimicrobials is being used in pig 
production. In order to be able to focus the actions for reducing antimicrobial use, more 
detailed knowledge on where the increasing amounts of drugs are being used is needed. 
The Danish Veterinary and Food Administration is funding a statistical program (VetStat) 
that provides information on the animal species for which a particular drug has been 
dispensed (Jensen et al. 2004). This material is available with a reasonable delay, and if 
imprudent use is noticed, actions can be taken rather quickly. When the data on animal 
species-specific use is available it can be evaluated together with national resistance data. 
In every case, the sales figures from wholesalers or pharmacies show the amounts of 
antimicrobials sold or dispensed for use in animals and that are also assumed to have ended 
up in the animals. Therefore, it must be noted that a certain amount is left in storage by the 
end-user and might be left unused or used later. However, no distinct information is available 
on how big a proportion of drugs sold or dispensed is wasted. 
In conclusion, wholesaler or pharmacy data seem to be useful in nationwide surveillance 
of trends in antibiotic consumption in animals. The data is also useful for international 
comparison when calculated in proportion to the annual meat production or number of 
animals of concern. This approach, however, does not take into account the differences in 
potency and hence in dosage of individual antimicrobials. 
6.2.2 Prescription studies 
Information from prescriptions can be gathered either from patient records or when the 
prescription is dispensed at a pharmacy. Collecting information from prescriptions is one way 
of gathering data from end-users or evaluating veterinarians’ prescribing patterns at distinct 
clinics. At best, circumstantial information can be derived from prescriptions, including the 
dosage, indication and length of treatment. 
When comparing the two prescription surveys that were performed, it was noted that there 
were no major differences in prescription practices for dogs and cats at the Veterinary 
Teaching Hospital (study A) and the prescriptions dispensed from the University Pharmacies 
(study B).  
In both of our studies, compliance to the Decree of Ministry and Agriculture and Forestry 
on the information that has to be included in a prescription (MMMa 7/EEO/2008) as well as 
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the prescribing patterns were also evaluated. One major problem with collecting data from 
prescriptions is the extent of missing information in them. Compared to the study performed 
by Weese (2006), in which no information on indications was collected, in our study 
performed at the Veterinary Teaching Hospital (study A) all missing data could be 
complemented from electronic patient records, and the indication and length of treatment 
could therefore in the majority of cases be confirmed. This allowed thorough evaluation of 
compliance with national prudent use guidelines (MMM 2003). Missing data were manually 
collected separately from each patient record. This was very time-consuming and 
burdensome. However, once all the data are entered in spreadsheets, analyses are easy to 
perform. 
Retrospective prescription studies carry the bias of missing information (Regula et al. 
2009). In our data collected from pharmacies (study B), only 30% of the prescriptions 
contained all the required information. This figure is similar to that in a study performed by 
Grave et al. (1991), where approximately 20% of the veterinary prescriptions in Norway 
contained all legally required information. The indication for use was given in 26% of the 
prescriptions (Grave et al. 1991). 
Another problem with prescription studies is the lack of knowledge about owner 
compliance. Compliance studies would be important to carry out, since it has been shown that 
treatment with sub-optimal dosing particularly provokes the development of resistance 
(Harigaya et al. 2009). One method for investigating owner compliance would be to carry out 
a prospective follow-up study on animals receiving a prescription for antimicrobials. After 
the course is due to have finished, the investigator could interview the owner by phone to 
assess the compliance and to gather information on possible adverse effects or lack of 
efficacy. 
6.2.3 Animal data forms 
Electronic patient records proved to be a very useful tool in collecting data. In the study on 
dogs and cats at the Veterinary Teaching Hospital, a search of prescriptions was carried out 
by the software administrator and delivered in a spreadsheet. The electronic patient record 
was utilized to complement missing data. In the equine study, all information was manually 
retrieved from the records by using a list of horses that underwent surgery. This list was 
gathered from the surgery log book. 
If the amount of data is limited, a manual search is not very burdensome. Moreover, if a 
single investigator collects the necessary information, the bias in calculating, for example, the 
number of days of treatment or in the interpretation of treatment plans is overcome. Coding is 
recommended when transferring the information to a spreadsheet, as this facilitates 
subsequent statistical analysis without having to carry out the coding separately. 
Data gathered from electronic or manual animal forms always carry the bias of unmarked 
medications. However, speculations on incomplete compliance cannot be made without 
knowing whether the dose was not actually given or whether it was given but not marked in 
the form. Therefore, when counting the lengths of treatment courses, the default value is days 
from the first dose to the last dose, unless there is a significant gap of more than one day. 
Occasional missed doses are noted as a lack of compliance. 
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Farm animal data are usually recorded in individual animal forms on which the farmer 
records every medication administered to each animal. The information is used for national 
surveillance, but also when milk is sent to the dairy or the animal is sent to slaughter. Larger 
farms use computer-based herd records, but smaller dairy farms in particular still use 
individual cow cards from which the artificial inseminator collects the information and 
transfers it to a national database. Once a larger proportion of the dairy farms register with 
the Finnish national healthcare system and database, Naseva, the collection of medication 
data from cattle will become more feasible. 
Limited search functions caused problems when compiling information from electronic 
patient records and herd records. Therefore, when implementing new EPR software in a 
clinic or animal hospital, especially in research facilities such as teaching hospitals, emphasis 
should be placed on adequate search functions. An optimal EPR in a teaching hospital would 
also include force functions that should, for example, not accept discharging of the patient 
without a diagnosis or a prescription without the dosage, length of treatment and indication. 
6.2.4 Questionnaire studies 
As in any other study, questionnaire studies require very thorough planning, statistical 
consultation and preferably testing of the questionnaire before sending it out to the target 
group or performing a phone interview.  
The study population that will be included has to be carefully selected, as it should form a 
representative sample of the source population. In our study C, weighted stratified sampling 
was used, which ensured that the respondents represented the source population well. Poor 
representativeness was pointed out as one of the limitations in the study by Chicoine et al. 
(2008) as their questionnaire was sent out only to members of the Western Canadian 
Association of Bovine Practitioners. Of all veterinary practitioners in Western Canada, 27% 
were members of the association. Therefore, it could not be excluded that the patterns of 
usage were different in non-members or non-respondents. 
In order to motivate, for example, busy practitioners to complete a questionnaire it needs 
to be concise and unambiguous.  A prospective study where, for instance, the veterinarian 
fills out the questionnaire instantly for each patient is considered to be more reliable than a 
retrospective study. Collecting information retrospectively using a questionnaire carries the 
risk of false information, as people are asked to rely on their memory, unless the respondent 
has kept a record of the issues in question. 
According to the study plan in our study C, each veterinarian was requested to fill out one 
form for every patient receiving antimicrobial treatment during the one-week study period. 
The questionnaire consisted of a cover page with questions about background information 
and 12 patient-specific questions. The questions were precoded and included lists of 
alternatives between which the respondent could choose. A space for “other” was also 
reserved. In our study the questionnaire was quite long and detailed, which might have 
influenced the response rate. In addition, the questionnaire was mailed to the sample 
population but no reminder was sent, which also might have somewhat lowered the response 
rate. By sending a reminder Chauvin et al. (2002) increased the response rate from 54% to 
70%, which can be considered satisfactory. In the Canadian study (Chicoine et al. 2008) the 
response rate was 41%, which is similar to the 38% response rate in our study. As in our 
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study, no reminder was sent out. The response rate might also be influenced by the topic of 
the study, people who are interested in the study subject are probably more likely to answer 
than those that are not interested or have limited knowledge about the subject. Paradiso-
Hardy and co-workers (2002) demonstrated that with a short and compact questionnaire, 
using reminders and choosing a limited study population with a special interest in the subject, 
it is possible to achieve a 100% response rate. 
As the percentage of people using the computer is rising, interest towards electronic 
questionnaire surveys is increasing. Electronic surveys are becoming more widely used and 
are stated as being cheaper, more practical and more reliable than paper questionnaires 
(Seebregts et al. 2009, Mukoma et al. 2004). Sending out cover letters and questionnaires by 
e-mail is fast, easy and cheap, and reminders to non-respondents are easy to send. The 
availability of e-mail addresses is one limiting factor, as well as the ability to reach those in 
the population who do not use a computer. One way of overcoming this problem is to send 
the questionnaire by mail to those not reachable by e-mail. 
Questionnaire studies provide a useful tool for collecting detailed information. However, 
it is challenging to formulate a questionnaire that gives the desired amount of reliable 
information without being too extensive and time-consuming. The response rate, 
representativeness and unambiguous and comprehensive answers are the most important 
measures of the validity of a questionnaire study. In our study, the response rate was 
moderate and the representativeness good. By sending out a reminder the response rate could 
have been increased significantly. 
6.3 Suitable methods for data collection in different animal groups 
6.3.1 Companion animals 
Companion animals are usually treated as single individuals and no withdrawal periods need 
to be considered. The variety of available products is wide, as human products can also be 
used. The development of resistance is more a concern of the individual patient than a herd 
problem or a problem for food safety. The impact of the development of resistant pathogens 
in companion animals cannot, however, be overlooked from a public health point of view. 
While the number of production animals in Finland continues to decline, the figures for 
companion animals are increasing. For example, in Denmark, the use of fluoroquinolones 
was banned for food-producing animals, but at the same time it was noted that this critically 
important class of antimicrobials is widely used in companion animals without any 
restrictions (Heuer et al. 2005). In Finland, the use of certain antimicrobials is forbidden in all 
animals. These include substances highly important in human medicine, such as 
glycopeptides, mupirocin and newer macrolides and fluoroquinolones (e.g. telithromycin and 
moxifloxacin) (MMMa 847/2008).  
Baseline information on the indication-based use of antimicrobials in companion animals, 
i.e. dogs and cats, in our study B was collected using a retrospective cross-sectional survey on 
prescriptions from pharmacies located in various parts of Finland. Prescriptions were also 
retrospectively reviewed utilizing electronic patient records at the Veterinary Teaching 
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Hospital (study A). Antimicrobial treatment patters were investigated prospectively by using 
a questionnaire sent to randomly-selected practitioners in Finland. 
The issue on missing information in retrospective prescription studies can be overcome if 
individual patient records can be utilized to complement the information. When information 
on prescription patterns is evaluated, the pharmacy databases are convenient for the 
collection of data.  
A prospective study performed on a random selection of small animal clinics would be an 
effective way of gathering information on antimicrobial use in companion animals. Using a 
computer-based questionnaire with obligatory fields minimizes the risk of missing 
information. Considering prescription studies, all electronic patient record programmes 
should contain obligatory fields in places where there is a legal demand for information to be 
given to the animal owner. In practice, an electronically written prescription should not be 
accepted by the computer unless all the required fields are completed. Especially in 
veterinary teaching hospitals, the programmes could be even more rigorous forcing the 
entering of information such as the diagnosis and dosage of medications. The more 
thoroughly the patient records are filled out, the more valuable data can be derived for 
research and teaching. 
On a national level, programmes such as VetStat in Denmark give crude animal species-
specific data on antimicrobial use and are valuable for comparing trends over years 
(DANMAP 2008). This information is useful for the national and international education of 
veterinarians and animal owners on the emerging threats of antimicrobial resistance or non-
compliance with prudent use guidelines.  
The results of the studies on dogs and cats showed no significant differences or 
discrepancies in the quality of information. For cats, three methods of data collection were 
used and the results were rather similar in all studies. The largest amount of information was 
derived from the electronic patient records of the Veterinary Teaching Hospital and the 
prospective questionnaire study of practitioners. The data collected retrospectively from the 
University Pharmacies was widely incomplete, as a large proportion of the prescriptions 
lacked at least one of the required parameters such as the indication, animal species or length 
of treatment. 
Animal owner compliance is a very interesting topic when assessing the utility of 
information derived, for example, from prescription studies. After all, the therapeutic effect is 
significantly dependent on how accurately the medication is given to the animal. Prescription 
studies measure the amount of antimicrobials dispensed from pharmacies or the prescription 
habits of veterinarians, but in order to evaluate actual usage, a study on owner compliance 
should be combined with the prescription study.  
6.3.2 Production animals (horses excluded) 
Farmers who keep production animals for human consumption are restricted by several legal 
requirements that have been established to ensure animal welfare and food safety. 
Medications administered to food producing animals have to be safe and therapeutically 
effective for the animal, but in addition, only medications that have proved to be safe for 
humans can be used in production animals. Regulatory authorities have established MRL 
values for the maximal amount of foreign substances allowed in edible t issues, milk and eggs 
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(Miller and Flynn 2000). Only substances that have a defined MRL can be used in production 
animals, and the determined withdrawal time has to be complied with. Farmers are also 
obliged to keep records of all medications given to individual animals or animal groups 
(MMMa 13/EEO/2000). The authorities are allowed to collect all necessary information from 
animal records kept by the farmers. At present, it is not compulsory for farmers to send any 
medical information to the authorities. However, the farms that have joined a herd health 
program have the opportunity to electronically report all disease information and medications 
to a national animal register. When the animal is sent to slaughter, the information is easily 
available for the slaughter house. 
In Finland, national animal registers do not systematically collect medical information 
from the entire life span of an individual animal. The electronic pig register (Sikava) does 
have a field where the farmer or the veterinarian can fill out administered or prescribed 
medications, but this specific service serves on a voluntary basis. A law on so-called chain 
information that was enacted in 2004 (EC 852/2004) requires farmers, who send live animals 
to be slaughtered, to keep records of all medications that have a withdrawal period (EC 
852/2004). A list of such medications also has to precede each animal when sent to the 
slaughterhouse (EC 853/2004). This law has been in force for poultry since 2006, pigs since 
2008, horses since 1 January 2009, and for other production animals this information is 
required from 1 January 2010. Information on medications has to be given for the three 
months prior to slaughter for all production animals except horses, for which the information 
has to be available for the previous 6 months (MMMa 134/2006). Data on medications 
combined with information on animal species and age will be valuable for research in the 
future. 
Information on antimicrobial usage in production animals can be collected by using 
questionnaires addressed to veterinarians, as in our study, or to farmers, as in the study of 
Rajić et al. (2006). A relatively short and concise questionnaire including background 
information can be mailed or sent by e-mail. A prospective questionnaire study on 
practitioners could ideally be complemented by a questionnaire directed to the farmers, 
enquiring the response to treatment and compliance with the given instructions. This could be 
performed by a telephone interview, which could reduce the fallacy of dishonest replies. 
In our study, the prospective questionnaire for veterinarians worked well, although a 
reminder could have given a higher response rate. 
To date, Finnish national data on the animal species-specific distribution of antimicrobials 
among animals has not been available. Therefore, only speculations on target species can be 
made from wholesaler statistics based on the animal species that a particular substance is 
registered for. In other countries such as Sweden or Denmark, where all medications are 
distributed through pharmacies, information can be collected on a species level (Grave et al. 
1999, Stege et al. 2003). 
6.3.3 Horses 
Horses are, in terms of law, somewhat complicated, as the animal owner is allowed in some 
cases to decide whether a horse is a companion animal or a production animal. According to 
Commission Regulation 504/2008, all equidae have to be identified and have an official 
identification document. Previously, only registered horses have had such a document. When 
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a horse is treated with a drug that prevents the animal from being slaughtered for human 
consumption, the veterinarian has to make a note in the identification document. The owner 
of a horse can also withdraw the horse from the food chain by requesting a note in the 
identification document. Due to this option, the assortment of antimicrobials is different for 
different categories of horses. 
As for other production animals, the animal owner has to keep a record of all medications 
carrying a withdrawal period that have been given to a horse (EC 852/2004). When the horse 
is sent to be slaughtered, information on medications administered to the animal during the 
previous six months has to precede the animal. The documentation has to include the names 
of drugs, dates of administration and withdrawal periods (EC 853/2004). From the registers 
of the slaughterhouses, information on antimicrobials administered to horses can then be 
collected. 
Data on antimicrobial use in horses can also be collected by using questionnaires sent to 
veterinary practitioners, equine clinics or horse owners. A prospective study on 
antimicrobials used in equine patients at one or several distinct clinics would provide 
valuable information on usage in hospitalized patients or outpatients, depending on the target 
group. Prospective studies performed, for example, on horses undergoing surgery in an 
equine hospital can be complemented by a questionnaire survey of the animal owners to 
evaluate the outcome, complications or compliance with the instructions.  
Retrospective data on antimicrobial use in horses can be collected by exploiting patient 
records or prescriptions; however, this entails the same issues as discussed previously. In our 
study on horses, the information on antimicrobial use was collected retrospectively and thus 
missing information could not be complemented. The heterogeneity of the population and 
types of surgical lesions also affected the choice of antimicrobial and duration of treatment, 
and only descriptive analyses were therefore applicable.  
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7 Conclusions 
1. When the clinical use of antimicrobials was explored, it was shown that the most common 
reason for antimicrobial treatment in dogs was pyoderma, which in the majority of the cases 
was treated with cephalexin. In cats, urinary tract infection was the most frequently 
diagnosed disease and treated with amoxicillin-clavulanate. 
Mastitis was the most common indication for antimicrobial treatment in cattle. For all 
indications in cattle, penicillin G was used in 81% of the cases.  
Horses treated as outpatients most commonly received penicillin G or trimethoprim-
sulfonamides for skin or wound infections. Hospitalized horses recovering from colic surgery 
were usually medicated with penicillin G in combination with gentamicin. 
 
2. Veterinarians complied well with the prevailing prudent use guidelines. Penicillin, 
aminopenicillins and first generation cephalosporins were widely used. Of the antimicrobials 
considered as reserve drugs, fluoroquinolones were used sparingly and in the majority of 
cases for an accepted indication such as urinary tract infections in dogs and mastitis caused 
by E. coli in dairy cattle. 
 
3. The method of data collection which is used has an important impact on the availability of 
information and the validity of the results. Therefore, several approaches were used to enable 
an extensive review of the data.  
 Data collected from EPRs gives a good overview of the usage patterns at the 
Veterinary Teaching Hospital. When the national databases for pig and dairy 
production are up and running and more farms join the national healthcare system, 
electronic herd records will provide valuable data on antimicrobial use in these animal 
species. 
 Data collection from prescriptions works well in situations where the pharmacy 
network is uniform and the data can be electronically collected in a national database. 
Unless the aim is to evaluate the prescribing habits of veterinarians at a limited 
number of sites, manual retrieval of information from prescriptions cannot be 
recommended. An end-user prescription study is at its best if followed up by a 
compliance study performed on the owners of the animals receiving the prescribed 
medication. 
 Questionnaire studies on practitioners provide a good overview of the antimicrobial 
usage patterns amongst a selected population of veterinarians. A well planned 
questionnaire with a reasonable number of questions can be sent out by mail and/or 
electronically. If followed by a reminder to non-respondents, it will most likely result 
in a reasonable response rate and truthful answers to questions about compliance with 
guidelines.  
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8 Future aspects  
The present studies provide a basis for the education of veterinarians and the revision of 
national guidelines on the prudent use of antimicrobials. It is important that veterinary 
practitioners are familiar with prudent use guidelines and comply with them. To combat the 
emergence of bacterial resistance, it is important that drugs known to promote resistance are 
used sparingly. This especially applies to cephalosporins and fluoroquinolones. 
Cephalosporins were widely used by Finnish veterinarians, and education on optional drugs 
should be provided. Concerning fluoroquinolones, the focus should be on judicious use and 
maintaining the efficacy of these important drugs. 
In the future monitoring of antimicrobial usage, following aspects should be considered: 
 The development of a continuous system for detailed surveillance should be 
emphasized.  
 The utilization of electronic systems would be worthwhile when, for example, 
planning questionnaire studies. Electronic questionnaires are easy to render and 
distribute. Remainders are also easy to send out by e-mail and will most likely 
positively influence the response rate. Analyses on electronic data are quicker, as the 
stage of entering the data from paper sheets into a database is left out. The risk of 
typing errors is also reduced. 
Electronic systems can also be used for the distribution of current information on 
antimicrobial use, prudent use guidelines and treatment recommendations. 
Educational material can be downloaded from a common website, for instance to a 
personal digital assistant, and used in daily clinical work. 
EPRs should be brought into use in a wider scale and developed further to include 
for example force functions in order to gather all relevant data. EPRs should also 
include electronic prescriptions with obligatory fields to ensure that all legally 
required information is inserted. 
 Owner compliance in veterinary medicine is a multifaceted issue. Veterinarians 
prescribe medication for an animal on the presumption that the owner will follow the 
instructions. For the individual animal, therapy failure is the worst consequence of 
non-compliance. Sub-optimal administration of antimicrobials can also lead to the 
development of bacterial resistance, which is a potential public health issue. 
Therefore, studies that collect information on the distribution of antimicrobials require 
complementary studies on compliance with the given instructions. Only then can valid 
conclusions on usage be made. 
 Indication-based usage of antimicrobials in pigs, poultry and fish should be 
investigated. Antimicrobials are used in large quantities in pig and poultry industry 
and it would therefore be important to know whether prudent use guidelines are being 
followed and if significant overuse of antimicrobials can be noted. 
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Appendix 1 
The use of antimicrobial drugs in animals – a survey questionnaire, 20–26 May 2002 
 
Background information about the veterinary surgeon 
 
Practice area:  
1. Province of Southern Finland 
2. Province of Western Finland 
3. Province of Eastern Finland 
4. Province of Oulu 
5. Province of Lapland 
6. Province of Åland 
 
Gender: 
1. Male 
2. Female 
 
Year of graduation: 
 
Specialist degree: 
1. Yes 
2. No 
 
If yes, please specify: 
 
Speciality area of practice (please select the most important): 
1. Small animals 
2. Cattle 
3. Pigs 
4. Horses 
5. Mixed practice 
6. Other. Please specify: _______________ 
7. I do not practice at present. 
 
Total number of patients during the week of this survey 
 
If you wish to participate in a prize draw and receive personal feedback, please provide 
your contact details below. 
 
Name: 
Veterinary surgeon’s ID number: 
Address: 
Telephone: 
Email: 
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1. Animal species 
(For the group treatment of production animals, please indicate the number of 
patients.) 
 
1. Dog 
2. Cat 
3. Horse 
4. Cattle _____ patients 
5. Pig _____ patients 
6. Fur animals _____ patients 
7. Fish _____ kg 
8. Other. Please specify: ____________ 
 
2. Please select as appropriate: 
 
1. Regular visit by appointment (surgery or farm) 
2. Emergency call (surgery or farm) 
3. Telephone prescription 
 
3. Main diagnosis (please select the key diagnosis for the treatment decision) 
Skin and ears, hypodermis 
1. Skin infection (pyoderma or cellulitis) 
2. Wound/abscess 
3. Outer ear infection 
 
Urinary tract 
4. Acute urinary tract infection (uncomplicated) 
5. Chronic or recurrent urinary tract infection 
6. Obstruction of the lower urinary tract (cats) 
 
Respiratory tract 
7. Signs of upper respiratory tract infection (pharyngitis, rhinitis, sneezing, etc.) 
8. Tracheobronchitis (including kennel cough) 
9. Pneumonia 
 
Mouth and digestive tract 
10. Gingivitis or other oral infection 
11. Acute intestinal infection 
12. Chronic intestinal infection 
13. Porcine diarrhoea or postweaning diarrhoea 
 
Other indications 
14. Endometritis/pyometra 
15. Acute mastitis (cattle) 
16. MMA syndrome/milk fever (pig) 
17. Arthritis or tail biting 
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18. Antimicrobial medication associated with a surgical procedure. 
Please specify the procedure: ____________ 
19. Other diagnosis. Please specify: ______________ 
 
4. Duration of signs before seeking medical advice (please select one) 
1. 0–3 days 
2. 4–7 days 
3. 8–14 days 
4. 15 or more days 
 
5. Which diagnostic examinations or procedures were carried out (please select all 
applicable)? 
1. Clinical examination 
2. Urinary dipstick 
3. Secretion microscopy 
4. Leucocytes 
5. Clavulanic acid test 
6. Bacterial culture and resistance 
7. X-ray or ultrasound examination 
8. CMT 
9. Other examination or procedure. Please specify: ____________ 
 
6. Please specify the antimicrobial drug administered to the patient by the veterinary 
surgeon during the visit: 
 
Name of preparation and dosage form 
 
Concentration 
 
Administered dose 
 
 
Name of preparation and dosage form 
 
Concentration 
 
Administered dose 
 
 
7. Please specify the oral or injected antimicrobial drug prescribed or dispensed for 
the patient’s further treatment: 
 
Name of preparation and dosage form 
 
Concentration 
 
75 
 
Duration of treatment ____________ days 
 
Prescribed/dispensed dose 
 
 
Name of preparation and dosage form 
 
Concentration 
 
Duration of treatment ____________ days 
 
Prescribed/dispensed dose 
 
8. Please specify the antimicrobial drug prescribed or dispensed to the patient as 
local treatment (e.g., intramammary infusions): 
 
Name of preparation and dosage form 
 
Concentration 
 
Duration of treatment ____________ days 
 
Prescribed/dispensed dose 
 
9. Did any of the following factors influence your choice of antimicrobial drug? 
 
1. Allergy (suspected) 
2. Patient’s other chronic illness 
3. Owner’s demand/request 
4. Recurrent/chronic infection 
5. Other. Please specify: ________________ 
 
10. Please select as appropriate: 
 
1. First visit due to this infection period 
2. Repeat visit 
 
11. Completed by (please provide your veterinary surgeon’s ID number, especially if 
you wish to receive feedback) 
 
 
 
 
 
 
